<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>6fc8d60849732353c701eb07f0250484-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft10{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft11{font-size:11px;font-family:Times;color:#211f21;}
	.ft12{font-size:10px;font-family:Times;color:#ffffff;}
	.ft13{font-size:13px;font-family:Times;color:#ffffff;}
	.ft14{font-size:19px;font-family:Times;color:#ac2b30;}
	.ft15{font-size:14px;font-family:Times;color:#211f21;}
	.ft16{font-size:7px;font-family:Times;color:#ad393e;}
	.ft17{font-size:8px;font-family:Times;color:#ad393e;}
	.ft18{font-size:10px;font-family:Times;color:#211f1f;}
	.ft19{font-size:10px;font-family:Times;color:#211f21;}
	.ft110{font-size:10px;font-family:Times;color:#211f21;}
	.ft111{font-size:10px;font-family:Times;color:#211f21;}
	.ft112{font-size:4px;font-family:Times;color:#211f21;}
	.ft113{font-size:10px;font-family:Times;color:#211f21;}
	.ft114{font-size:9px;font-family:Times;color:#211f21;}
	.ft115{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft116{font-size:11px;font-family:Times;color:#211f21;}
	.ft117{font-size:11px;font-family:Times;color:#211f21;}
	.ft118{font-size:5px;font-family:Times;color:#211f21;}
	.ft119{font-size:13px;font-family:Times;color:#211f21;}
	.ft120{font-size:13px;font-family:Times;color:#211f21;}
	.ft121{font-size:7px;line-height:21px;font-family:Times;color:#ad393e;}
	.ft122{font-size:10px;line-height:28px;font-family:Times;color:#211f1f;}
	.ft123{font-size:11px;line-height:18px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page1-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft10">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft11">19575</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft10">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:68px;left:77px;white-space:nowrap" class="ft12"><b>www.impactjournals.com/oncotarget/&#160;</b></p>
<p style="position:absolute;top:66px;left:625px;white-space:nowrap" class="ft13"><b>Oncotarget, Vol. 7, No. 15</b></p>
<p style="position:absolute;top:123px;left:87px;white-space:nowrap" class="ft14"><b>Use of genetically&#160;encoded, light-gated ion translocators to&#160;</b></p>
<p style="position:absolute;top:149px;left:87px;white-space:nowrap" class="ft14"><b>control tumorigenesis</b></p>
<p style="position:absolute;top:191px;left:87px;white-space:nowrap" class="ft122"><b>Brook T. Chernet1, Dany S. Adams1, Maria Lobikin1, Michael Levin1<br/>1</b>&#160;Center for Regenerative and Developmental Biology and Department of Biology Tufts University, Medford, MA 02155, USA<br/><b>Correspondence to:&#160;</b></p>
<p style="position:absolute;top:240px;left:223px;white-space:nowrap" class="ft110">Michael Levin,&#160;<b>e-mail:&#160;</b>michael.levin@tufts.edu</p>
<p style="position:absolute;top:263px;left:87px;white-space:nowrap" class="ft19"><b>Keywords:</b></p>
<p style="position:absolute;top:263px;left:159px;white-space:nowrap" class="ft111"><i>&#160;v</i></p>
<p style="position:absolute;top:272px;left:170px;white-space:nowrap" class="ft112"><i>mem, bioelectricity, voltage, RAS, optogenetics</i></p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft113"><i><b>Received:&#160;</b>November 22,&#160;2015&#160;</i></p>
<p style="position:absolute;top:286px;left:353px;white-space:nowrap" class="ft113"><i><b>Accepted:&#160;</b>February 11,&#160;2016&#160;</i></p>
<p style="position:absolute;top:286px;left:609px;white-space:nowrap" class="ft113"><i><b>Published:&#160;</b>March 16,&#160;2016</i></p>
<p style="position:absolute;top:333px;left:87px;white-space:nowrap" class="ft115"><b>ABSTRACT</b></p>
<p style="position:absolute;top:374px;left:177px;white-space:nowrap" class="ft116"><b>It has long been known that&#160;the resting potential of tumor cells is depolarized&#160;</b></p>
<p style="position:absolute;top:393px;left:141px;white-space:nowrap" class="ft123"><b>relative to&#160;their normal counterparts. More recent work has provided evidence that&#160;<br/>resting potential&#160;is not just a readout of cell state: it&#160;regulates cell behavior as well.&#160;<br/>Thus, the ability&#160;to&#160;control resting potential&#160;</b></p>
<p style="position:absolute;top:430px;left:486px;white-space:nowrap" class="ft117"><i><b>in vivo&#160;</b></i><b>would provide a powerful new&#160;</b></p>
<p style="position:absolute;top:450px;left:141px;white-space:nowrap" class="ft123"><b>tool for the study and treatment&#160;of tumors, a tool capable of revealing living-state&#160;<br/>physiological&#160;information&#160;impossible&#160;to&#160;obtain&#160;using&#160;molecular&#160;tools&#160;applied&#160;to&#160;<br/>isolated&#160;cell&#160;components.&#160;Here&#160;we&#160;describe&#160;the&#160;first&#160;use&#160;of&#160;optogenetics&#160;to&#160;manipulate&#160;<br/>ion-flux&#160;mediated&#160;regulation&#160;of&#160;membrane&#160;potential&#160;specifically&#160;to&#160;prevent&#160;and&#160;cause&#160;<br/>regression of oncogene-induced tumors. Injection of mutant-KRAS mRNA induces&#160;<br/>tumor-like&#160;structures&#160;with&#160;many&#160;documented&#160;similarities&#160;to&#160;tumors,&#160;in&#160;</b></p>
<p style="position:absolute;top:544px;left:711px;white-space:nowrap" class="ft117"><i><b>Xenopus</b></i><b>&#160;</b></p>
<p style="position:absolute;top:563px;left:141px;white-space:nowrap" class="ft116"><b>tadpoles.&#160;We&#160;show&#160;that&#160;expression&#160;and&#160;activation&#160;of&#160;either&#160;</b></p>
<p style="position:absolute;top:563px;left:608px;white-space:nowrap" class="ft117"><i><b>ChR2D156A</b></i><b>,&#160;a&#160;blue-light&#160;</b></p>
<p style="position:absolute;top:582px;left:141px;white-space:nowrap" class="ft116"><b>activated cation channel, or&#160;</b></p>
<p style="position:absolute;top:582px;left:353px;white-space:nowrap" class="ft117"><i><b>Arch</b></i><b>, a green-light&#160;activated proton pump, both of which&#160;</b></p>
<p style="position:absolute;top:601px;left:141px;white-space:nowrap" class="ft123"><b>hyperpolarize&#160;cells,&#160;significantly&#160;lowers&#160;the&#160;incidence&#160;of&#160;KRAS&#160;tumor&#160;formation.&#160;<br/>Excitingly,&#160;we&#160;also&#160;demonstrate&#160;that&#160;activation&#160;of&#160;co-expressed&#160;light-activated&#160;ion&#160;<br/>translocators&#160;</b></p>
<p style="position:absolute;top:638px;left:246px;white-space:nowrap" class="ft117"><i><b>after</b></i><b>&#160;tumor&#160;formation&#160;significantly&#160;increases&#160;the&#160;frequency&#160;with&#160;which&#160;</b></p>
<p style="position:absolute;top:658px;left:141px;white-space:nowrap" class="ft123"><b>the&#160;tumors regress in&#160;a&#160;process&#160;called&#160;normalization.&#160;These&#160;data&#160;demonstrate&#160;an&#160;<br/>optogenetic&#160;approach&#160;to&#160;dissect&#160;the&#160;biophysics&#160;of&#160;cancer.&#160;Moreover,&#160;they&#160;provide&#160;<br/>proof-of-principle for&#160;a&#160;novel&#160;class of&#160;interventions, directed at&#160;regulating cell&#160;state&#160;<br/>by targeting physiological regulators that can over-ride the presence of mutations.</b></p>
<p style="position:absolute;top:772px;left:87px;white-space:nowrap" class="ft115"><b>INTRODUCTION</b></p>
<p style="position:absolute;top:812px;left:123px;white-space:nowrap" class="ft119">Recent work&#160;has highlighted the instructive roles of&#160;</p>
<p style="position:absolute;top:830px;left:87px;white-space:nowrap" class="ft119">bioelectric&#160;signals&#160;in&#160;large-scale&#160;pattern&#160;formation&#160;during&#160;</p>
<p style="position:absolute;top:848px;left:87px;white-space:nowrap" class="ft119">embryogenesis and regeneration [1–7].&#160;We are beginning&#160;</p>
<p style="position:absolute;top:866px;left:87px;white-space:nowrap" class="ft119">to understand how these ionic signals function as a layer&#160;</p>
<p style="position:absolute;top:884px;left:87px;white-space:nowrap" class="ft119">of physiological control and how they are integrated&#160;</p>
<p style="position:absolute;top:902px;left:87px;white-space:nowrap" class="ft119">mechanistically with biochemical and genetic pathways&#160;</p>
<p style="position:absolute;top:921px;left:87px;white-space:nowrap" class="ft119">[8–12]. Indeed, because bioelectrical states regulate&#160;</p>
<p style="position:absolute;top:939px;left:87px;white-space:nowrap" class="ft119">differentiation,&#160;migration, and&#160;proliferation&#160;[13–17],&#160;</p>
<p style="position:absolute;top:957px;left:87px;white-space:nowrap" class="ft119">these physiological circuits are an ideal candidate for an&#160;</p>
<p style="position:absolute;top:975px;left:87px;white-space:nowrap" class="ft119">important aspect of the patterning cues that go awry in&#160;</p>
<p style="position:absolute;top:993px;left:87px;white-space:nowrap" class="ft119">cancer [18–23]. Bioelectricity has long been implicated&#160;</p>
<p style="position:absolute;top:1012px;left:87px;white-space:nowrap" class="ft119">in neoplasm [24, 25], and recent molecular efforts have&#160;</p>
<p style="position:absolute;top:1030px;left:87px;white-space:nowrap" class="ft119">focused&#160;on ion&#160;channels&#160;as&#160;important cancer&#160;targets&#160;</p>
<p style="position:absolute;top:1048px;left:87px;white-space:nowrap" class="ft119">[26–33],&#160;and&#160;ion&#160;channel&#160;drugs&#160;as&#160;a&#160;promising&#160;class&#160;of&#160;</p>
<p style="position:absolute;top:1066px;left:87px;white-space:nowrap" class="ft119">therapies [13, 34–38].</p>
<p style="position:absolute;top:774px;left:523px;white-space:nowrap" class="ft119">Importantly however, it is beginning to be seen&#160;</p>
<p style="position:absolute;top:792px;left:487px;white-space:nowrap" class="ft119">that modulating carcinogenesis and metastasis is not as&#160;</p>
<p style="position:absolute;top:810px;left:487px;white-space:nowrap" class="ft119">simple as targeting individual ion channel genes for loss-&#160;</p>
<p style="position:absolute;top:828px;left:487px;white-space:nowrap" class="ft119">or gain-of function applications.&#160;The key parameter can be&#160;</p>
<p style="position:absolute;top:847px;left:487px;white-space:nowrap" class="ft119">a complex, non-cell-autonomous physiological state not&#160;</p>
<p style="position:absolute;top:865px;left:487px;white-space:nowrap" class="ft119">intrinsically&#160;limited&#160;to&#160;any&#160;one&#160;specific&#160;channel&#160;or&#160;pump&#160;</p>
<p style="position:absolute;top:883px;left:487px;white-space:nowrap" class="ft119">[3, 39–43].&#160;Thus, it is important to exploit amenable model&#160;</p>
<p style="position:absolute;top:902px;left:487px;white-space:nowrap" class="ft119">systems to understand how&#160;aspects of cancer are regulated&#160;</p>
<p style="position:absolute;top:920px;left:487px;white-space:nowrap" class="ft119">by bioelectrical&#160;states of tissues&#160;<i>in vivo</i>. However, to fully&#160;</p>
<p style="position:absolute;top:938px;left:487px;white-space:nowrap" class="ft119">understand and exploit the control of cell functions via&#160;</p>
<p style="position:absolute;top:956px;left:487px;white-space:nowrap" class="ft119">bioelectrical signaling requires the development of new&#160;</p>
<p style="position:absolute;top:975px;left:487px;white-space:nowrap" class="ft119">techniques&#160;that&#160;allow&#160;ion&#160;flux&#160;to&#160;be&#160;influenced&#160;in&#160;any&#160;cell/</p>
<p style="position:absolute;top:993px;left:487px;white-space:nowrap" class="ft119">tissue of interest with much greater spatio-temporal control&#160;</p>
<p style="position:absolute;top:1011px;left:487px;white-space:nowrap" class="ft119">than&#160;has&#160;been&#160;possible&#160;to&#160;date&#160;with&#160;pharmacological&#160;or&#160;</p>
<p style="position:absolute;top:1030px;left:487px;white-space:nowrap" class="ft119">genetic approaches.</p>
<p style="position:absolute;top:1048px;left:523px;white-space:nowrap" class="ft119">One exciting candidate for achieving improved&#160;</p>
<p style="position:absolute;top:1066px;left:487px;white-space:nowrap" class="ft119">spatio-temporal&#160;control&#160;of&#160;ion&#160;flux&#160;is&#160;optogenetics&#160;[44–47].&#160;&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>6fc8d60849732353c701eb07f0250484-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft20{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft21{font-size:11px;font-family:Times;color:#211f21;}
	.ft22{font-size:13px;font-family:Times;color:#211f21;}
	.ft23{font-size:13px;font-family:Times;color:#211f21;}
	.ft24{font-size:6px;font-family:Times;color:#211f21;}
	.ft25{font-size:6px;font-family:Times;color:#211f21;}
	.ft26{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft27{font-size:14px;font-family:Times;color:#211f21;}
	.ft28{font-size:14px;font-family:Times;color:#211f21;}
	.ft29{font-size:7px;font-family:Times;color:#211f21;}
	.ft210{font-size:7px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page2-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft20">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft21">19576</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft20">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft22">Optogenetics&#160;is the expression of light-gated&#160;ion&#160;</p>
<p style="position:absolute;top:89px;left:87px;white-space:nowrap" class="ft22">translocators and enzymes, with different kinetics and&#160;</p>
<p style="position:absolute;top:107px;left:87px;white-space:nowrap" class="ft22">different wavelengths of activation, to control downstream&#160;</p>
<p style="position:absolute;top:125px;left:87px;white-space:nowrap" class="ft22">processes,&#160;&#160;such&#160;&#160;as&#160;&#160;ion&#160;&#160;flux&#160;&#160;or&#160;&#160;enzyme&#160;&#160;activity.&#160;&#160;It&#160;&#160;has&#160;</p>
<p style="position:absolute;top:143px;left:87px;white-space:nowrap" class="ft22">primarily&#160;been used as a precise tool to control neural and&#160;</p>
<p style="position:absolute;top:161px;left:87px;white-space:nowrap" class="ft22">muscle&#160;excitation/inhibition,&#160;and&#160;to&#160;regulate&#160;biochemical&#160;</p>
<p style="position:absolute;top:180px;left:87px;white-space:nowrap" class="ft22">processes [44, 45]. Extending the use of optogenetics to&#160;</p>
<p style="position:absolute;top:198px;left:87px;white-space:nowrap" class="ft22">non-excitable&#160;cells [48], our lab has successfully initiated&#160;</p>
<p style="position:absolute;top:216px;left:87px;white-space:nowrap" class="ft23"><i>Xenopus</i>&#160;tail regeneration by hyperpolarizing cells using&#160;</p>
<p style="position:absolute;top:234px;left:87px;white-space:nowrap" class="ft22">the&#160;light-dependent H+&#160;pump, Archaerhodopsin,&#160;thereby&#160;</p>
<p style="position:absolute;top:252px;left:87px;white-space:nowrap" class="ft22">reversing the normal, age-dependent loss of regenerative&#160;</p>
<p style="position:absolute;top:271px;left:87px;white-space:nowrap" class="ft22">ability [49]. Building on this work and recent data on&#160;</p>
<p style="position:absolute;top:289px;left:87px;white-space:nowrap" class="ft22">the bioelectric control of tumorigenesis [43, 50], we&#160;</p>
<p style="position:absolute;top:307px;left:87px;white-space:nowrap" class="ft22">investigated here the potential applicability of optogenetics&#160;</p>
<p style="position:absolute;top:325px;left:87px;white-space:nowrap" class="ft22">to hyperpolarization-induced tumor suppression.&#160;</p>
<p style="position:absolute;top:343px;left:123px;white-space:nowrap" class="ft23"><i>Xenopus laevis</i>&#160;is a model system that facilitates&#160;</p>
<p style="position:absolute;top:362px;left:87px;white-space:nowrap" class="ft22">the investigation of the role of bioelectric signals in&#160;</p>
<p style="position:absolute;top:380px;left:87px;white-space:nowrap" class="ft22">morphogenesis and cellular regulation [12, 51–55].&#160;The&#160;</p>
<p style="position:absolute;top:398px;left:87px;white-space:nowrap" class="ft22">organism&#160;also&#160;provides&#160;a powerful model&#160;system&#160;for&#160;</p>
<p style="position:absolute;top:416px;left:87px;white-space:nowrap" class="ft22">studying cancer [4, 50, 56–60] due to its tractability for&#160;</p>
<p style="position:absolute;top:435px;left:87px;white-space:nowrap" class="ft22">optical, molecular, and electrophysiological studies, and&#160;</p>
<p style="position:absolute;top:453px;left:87px;white-space:nowrap" class="ft22">to the many conserved pathways it shares with humans&#160;&#160;</p>
<p style="position:absolute;top:471px;left:87px;white-space:nowrap" class="ft22">[61–66]. Moreover, this model system offers well&#160;</p>
<p style="position:absolute;top:489px;left:87px;white-space:nowrap" class="ft22">characterized tumor-inducing molecular reagents (the&#160;</p>
<p style="position:absolute;top:507px;left:87px;white-space:nowrap" class="ft22">human&#160;oncogenes&#160;<i>Gli1</i>,&#160;<i>Xrel3</i>,&#160;<i>p53Trp248&#160;</i>and&#160;<i>KRASG12D</i>),&#160;</p>
<p style="position:absolute;top:526px;left:87px;white-space:nowrap" class="ft22">whose expression&#160;results&#160;in&#160;induced&#160;tumor-like&#160;structures&#160;</p>
<p style="position:absolute;top:544px;left:87px;white-space:nowrap" class="ft22">(ITLSs) with many of the hallmarks of mammalian&#160;</p>
<p style="position:absolute;top:562px;left:87px;white-space:nowrap" class="ft22">tumors: increased mitotic activity, induced vasculogenesis,&#160;</p>
<p style="position:absolute;top:580px;left:87px;white-space:nowrap" class="ft22">increased hypoxia, acidic microenvironment,&#160;</p>
<p style="position:absolute;top:599px;left:87px;white-space:nowrap" class="ft22">disorganization of normal cell architecture, and ability to&#160;</p>
<p style="position:absolute;top:617px;left:87px;white-space:nowrap" class="ft22">trigger an innate immune response [3, 4, 50, 67, 68].&#160;</p>
<p style="position:absolute;top:635px;left:123px;white-space:nowrap" class="ft22">In addition to exhibiting other classic tumor&#160;</p>
<p style="position:absolute;top:653px;left:87px;white-space:nowrap" class="ft22">characteristics, these tumor-like structures maintain a&#160;</p>
<p style="position:absolute;top:671px;left:87px;white-space:nowrap" class="ft22">depolarized&#160;membrane&#160;voltage.&#160;This&#160;bioelectric&#160;signature&#160;</p>
<p style="position:absolute;top:690px;left:87px;white-space:nowrap" class="ft22">can be used to detect prospective ITLS regions before&#160;</p>
<p style="position:absolute;top:708px;left:87px;white-space:nowrap" class="ft22">they become morphologically apparent [42]. Moreover,&#160;</p>
<p style="position:absolute;top:726px;left:87px;white-space:nowrap" class="ft22">we have shown that this depolarization is not only a&#160;</p>
<p style="position:absolute;top:744px;left:87px;white-space:nowrap" class="ft22">signature but is functionally required for tumorigenesis,&#160;</p>
<p style="position:absolute;top:762px;left:87px;white-space:nowrap" class="ft22">by&#160;&#160;demonstrating&#160;&#160;that&#160;&#160;artificially&#160;&#160;hyperpolarizing&#160;</p>
<p style="position:absolute;top:781px;left:87px;white-space:nowrap" class="ft22">oncogene-expressing&#160;cells,&#160;by&#160;expressing&#160;any&#160;of&#160;several&#160;</p>
<p style="position:absolute;top:799px;left:87px;white-space:nowrap" class="ft22">ion&#160;channels,&#160;significantly&#160;reduces&#160;the&#160;incidence&#160;of&#160;ITLS&#160;</p>
<p style="position:absolute;top:817px;left:87px;white-space:nowrap" class="ft22">formation&#160;&#160;despite&#160;&#160;high&#160;&#160;levels&#160;&#160;of&#160;&#160;otherwise-sufficient&#160;</p>
<p style="position:absolute;top:835px;left:87px;white-space:nowrap" class="ft22">oncogene expression in the same tissue [3, 4].&#160;</p>
<p style="position:absolute;top:854px;left:123px;white-space:nowrap" class="ft22">Given the importance of bioelectric signaling, and&#160;</p>
<p style="position:absolute;top:872px;left:87px;white-space:nowrap" class="ft22">the need for high-resolution manipulation both for the&#160;</p>
<p style="position:absolute;top:890px;left:87px;white-space:nowrap" class="ft22">clinic and for probing the basic biology of this process, we&#160;</p>
<p style="position:absolute;top:908px;left:87px;white-space:nowrap" class="ft22">explored whether optogenetics can be used to improve our&#160;</p>
<p style="position:absolute;top:926px;left:87px;white-space:nowrap" class="ft22">ability to regulate, in both time and space, the bioelectric&#160;</p>
<p style="position:absolute;top:945px;left:87px;white-space:nowrap" class="ft22">signaling that is disrupted during cancer.&#160;We hypothesized&#160;</p>
<p style="position:absolute;top:963px;left:87px;white-space:nowrap" class="ft22">that spatio-temporally-controllable light-gated ion&#160;</p>
<p style="position:absolute;top:981px;left:87px;white-space:nowrap" class="ft22">translocators&#160;would&#160;enable&#160;precise&#160;control&#160;over&#160;ion&#160;flux&#160;</p>
<p style="position:absolute;top:999px;left:87px;white-space:nowrap" class="ft22">(and therefore membrane voltage (V</p>
<p style="position:absolute;top:1011px;left:317px;white-space:nowrap" class="ft24">mem)) in a tissue of&#160;</p>
<p style="position:absolute;top:1017px;left:87px;white-space:nowrap" class="ft22">interest,&#160;and&#160;thus&#160;we&#160;sought&#160;to&#160;extend&#160;optogenetics&#160;to&#160;the&#160;</p>
<p style="position:absolute;top:1036px;left:87px;white-space:nowrap" class="ft22">biophysical control of oncogene-dependent tumorigenesis.&#160;</p>
<p style="position:absolute;top:1054px;left:123px;white-space:nowrap" class="ft22">To test the ability of optogenetic tools to alter&#160;</p>
<p style="position:absolute;top:1072px;left:87px;white-space:nowrap" class="ft22">endogenous V</p>
<p style="position:absolute;top:1083px;left:174px;white-space:nowrap" class="ft24">mem&#160;and thereby suppress ITLS growth and&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft22">promote tissue normalization, we used&#160;Archaerhodopsin&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft22">(<i>Arch</i>)&#160;[69],&#160;a&#160;light-gated&#160;H+&#160;transporter that&#160;hyperpolarizes&#160;</p>
<p style="position:absolute;top:107px;left:487px;white-space:nowrap" class="ft22">cells&#160;&#160;[49,&#160;&#160;70].&#160;&#160;We&#160;&#160;confirm&#160;&#160;here&#160;&#160;that&#160;&#160;microinjection&#160;&#160;of&#160;</p>
<p style="position:absolute;top:125px;left:487px;white-space:nowrap" class="ft23"><i>KRASG12D</i>&#160;[71] mRNA, a tumor-inducing KRAS mutant,&#160;</p>
<p style="position:absolute;top:143px;left:487px;white-space:nowrap" class="ft22">results&#160;in&#160;the&#160;formation&#160;of&#160;the&#160;ITLSs&#160;that&#160;we&#160;have&#160;</p>
<p style="position:absolute;top:161px;left:487px;white-space:nowrap" class="ft22">previously shown to exhibit classic hallmarks of tumors,&#160;</p>
<p style="position:absolute;top:179px;left:487px;white-space:nowrap" class="ft22">including histopathology, increased proliferation, lack of&#160;</p>
<p style="position:absolute;top:198px;left:487px;white-space:nowrap" class="ft22">differentiation, attraction of vasculature, etc. [3, 4,&#160;41].&#160;</p>
<p style="position:absolute;top:216px;left:487px;white-space:nowrap" class="ft22">We&#160;then&#160;demonstrate&#160;that&#160;co-injection&#160;of&#160;<i>Arch</i>&#160;mRNA&#160;and&#160;</p>
<p style="position:absolute;top:234px;left:487px;white-space:nowrap" class="ft22">subsequent expression of&#160;<i>Arch</i>&#160;in&#160;<i>KRASG12D</i>-expressing&#160;</p>
<p style="position:absolute;top:252px;left:487px;white-space:nowrap" class="ft22">cells, followed by a 24-hour light-activation of the&#160;<i>Arch</i>&#160;</p>
<p style="position:absolute;top:270px;left:487px;white-space:nowrap" class="ft22">transporter, reduced ITLS incidence by 32%.&#160;We also&#160;</p>
<p style="position:absolute;top:288px;left:487px;white-space:nowrap" class="ft22">show that&#160;suppression&#160;and&#160;normalization&#160;of&#160;ITLSs&#160;are&#160;not&#160;</p>
<p style="position:absolute;top:307px;left:487px;white-space:nowrap" class="ft22">specific&#160;to&#160;<i>Arch</i>,&#160;but&#160;can&#160;also&#160;be&#160;accomplished&#160;by&#160;injection&#160;</p>
<p style="position:absolute;top:325px;left:487px;white-space:nowrap" class="ft22">of a different optogenetic reagent, channelrhodopsin-2&#160;</p>
<p style="position:absolute;top:343px;left:487px;white-space:nowrap" class="ft22">(<i>ChR2D156A</i>) [72]. Most interestingly, by delaying the&#160;</p>
<p style="position:absolute;top:361px;left:487px;white-space:nowrap" class="ft22">activation of&#160;<i>ChR2D156A</i>&#160;until ~ stage 35, we were able to&#160;</p>
<p style="position:absolute;top:379px;left:487px;white-space:nowrap" class="ft22">convert&#160;fully&#160;developed&#160;ITLSs into&#160;normal&#160;cells.&#160;Thus we&#160;</p>
<p style="position:absolute;top:397px;left:487px;white-space:nowrap" class="ft22">demonstrate the utility of&#160;optogenetics to&#160;suppress&#160;ITLS&#160;</p>
<p style="position:absolute;top:416px;left:487px;white-space:nowrap" class="ft22">formation and to promote normalization of existing ITLSs&#160;</p>
<p style="position:absolute;top:434px;left:487px;white-space:nowrap" class="ft22">into wildtype tissue.&#160;</p>
<p style="position:absolute;top:470px;left:487px;white-space:nowrap" class="ft26"><b>RESULTS</b></p>
<p style="position:absolute;top:510px;left:487px;white-space:nowrap" class="ft27"><b>Injection of&#160;<i>KRASG12D</b>&#160;</i><b>results in ITLS formation</b></p>
<p style="position:absolute;top:545px;left:523px;white-space:nowrap" class="ft22">To study the usability of&#160;V</p>
<p style="position:absolute;top:556px;left:687px;white-space:nowrap" class="ft24">mem-altering optogenetic&#160;</p>
<p style="position:absolute;top:563px;left:487px;white-space:nowrap" class="ft22">tools in oncogene-mediated tumorigenesis, we expressed&#160;</p>
<p style="position:absolute;top:581px;left:487px;white-space:nowrap" class="ft22">a human oncogene in&#160;<i>Xenopus</i>&#160;&#160;embryos.&#160;&#160;Injection&#160;&#160;of&#160;</p>
<p style="position:absolute;top:599px;left:487px;white-space:nowrap" class="ft22">the oncogene&#160;<i>KRASG12D</i>&#160;[71] into&#160;<i>Xenopus&#160;&#160;</i>embryos&#160;</p>
<p style="position:absolute;top:617px;left:487px;white-space:nowrap" class="ft22">(1 blastomere at the 16-cell stage) induced ITLSs&#160;</p>
<p style="position:absolute;top:636px;left:487px;white-space:nowrap" class="ft22">(Figure&#160;1A), which have previously been shown to exhibit&#160;</p>
<p style="position:absolute;top:654px;left:487px;white-space:nowrap" class="ft22">many&#160;&#160;of&#160;&#160;the&#160;&#160;defining&#160;&#160;hallmarks&#160;&#160;of&#160;&#160;their&#160;&#160;mammalian&#160;</p>
<p style="position:absolute;top:672px;left:487px;white-space:nowrap" class="ft22">counterparts.&#160;</p>
<p style="position:absolute;top:708px;left:487px;white-space:nowrap" class="ft28"><i><b>ChR2D156A</b></i><b>&#160;activity alters membrane voltage of&#160;</b></p>
<p style="position:absolute;top:728px;left:487px;white-space:nowrap" class="ft28"><i><b>Xenopus</b></i><b>&#160;embryonic cells</b></p>
<p style="position:absolute;top:763px;left:523px;white-space:nowrap" class="ft22">To&#160;allow&#160;modulation&#160;of&#160;V</p>
<p style="position:absolute;top:774px;left:690px;white-space:nowrap" class="ft24">mem&#160;via&#160;light&#160;activation&#160;</p>
<p style="position:absolute;top:781px;left:487px;white-space:nowrap" class="ft22">of a channelrhodopsin-2 (<i>ChR2D156A</i>) channel,&#160;<i>ChR2D156A</i>&#160;</p>
<p style="position:absolute;top:799px;left:487px;white-space:nowrap" class="ft22">mRNA&#160;&#160;was&#160;&#160;injected&#160;&#160;into&#160;&#160;1&#160;&#160;cell&#160;&#160;of&#160;&#160;a&#160;&#160;2-cell&#160;&#160;embryo,&#160;</p>
<p style="position:absolute;top:818px;left:487px;white-space:nowrap" class="ft22">allowing&#160;the&#160;uninjected&#160;side&#160;to&#160;serve&#160;as&#160;an&#160;internal&#160;control&#160;</p>
<p style="position:absolute;top:836px;left:487px;white-space:nowrap" class="ft22">(Figure&#160;1).&#160;<i>ChR2D156A</i>&#160;&#160;is&#160;&#160;a&#160;&#160;non-specific&#160;&#160;cation&#160;&#160;channel&#160;</p>
<p style="position:absolute;top:854px;left:487px;white-space:nowrap" class="ft22">that, at physiological pH, passes mostly protons, but&#160;</p>
<p style="position:absolute;top:872px;left:487px;white-space:nowrap" class="ft22">there&#160;is&#160;also&#160;significant&#160;Na+&#160;and K+&#160;flux&#160;[45]&#160;[73];&#160;it&#160;was&#160;</p>
<p style="position:absolute;top:890px;left:487px;white-space:nowrap" class="ft22">selected because of the low incidence of side effects in&#160;</p>
<p style="position:absolute;top:908px;left:487px;white-space:nowrap" class="ft23"><i>Xenopus</i>&#160;embryos&#160;[48].&#160;Because&#160;of&#160;the&#160;extremely&#160;low&#160;ion&#160;</p>
<p style="position:absolute;top:927px;left:487px;white-space:nowrap" class="ft22">concentration&#160;of&#160;the&#160;surrounding&#160;medium,&#160;light&#160;activation&#160;</p>
<p style="position:absolute;top:945px;left:487px;white-space:nowrap" class="ft22">of this channel is predicted to hyperpolarize those cells&#160;</p>
<p style="position:absolute;top:963px;left:487px;white-space:nowrap" class="ft22">due&#160;to&#160;efflux&#160;of&#160;cations;&#160;Table&#160;1&#160;gives&#160;the&#160;internal&#160;and&#160;</p>
<p style="position:absolute;top:981px;left:487px;white-space:nowrap" class="ft22">external&#160;ion&#160;concentrations.&#160;Injected&#160;embryos,&#160;raised&#160;to&#160;</p>
<p style="position:absolute;top:999px;left:487px;white-space:nowrap" class="ft22">stage 18, were exposed to blue light then imaged using&#160;</p>
<p style="position:absolute;top:1018px;left:487px;white-space:nowrap" class="ft22">the membrane voltage-sensitive dye DiBAC</p>
<p style="position:absolute;top:1029px;left:755px;white-space:nowrap" class="ft24">4&#160;(3), a semi-</p>
<p style="position:absolute;top:1036px;left:487px;white-space:nowrap" class="ft22">quantitative&#160;method that&#160;has&#160;been&#160;extensively&#160;used&#160;to&#160;</p>
<p style="position:absolute;top:1054px;left:487px;white-space:nowrap" class="ft22">monitor&#160;relative&#160;resting-potential&#160;differences&#160;among&#160;cells&#160;</p>
<p style="position:absolute;top:1072px;left:487px;white-space:nowrap" class="ft23"><i>in vivo</i>&#160;[49, 54, 74–78].&#160;As predicted, we observed that&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>6fc8d60849732353c701eb07f0250484-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft30{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft31{font-size:11px;font-family:Times;color:#211f21;}
	.ft32{font-size:13px;font-family:Times;color:#211f21;}
	.ft33{font-size:14px;font-family:Times;color:#211f21;}
	.ft34{font-size:14px;font-family:Times;color:#211f21;}
	.ft35{font-size:7px;font-family:Times;color:#211f21;}
	.ft36{font-size:13px;font-family:Times;color:#211f21;}
	.ft37{font-size:6px;font-family:Times;color:#211f21;}
	.ft38{font-size:13px;font-family:Times;color:#000000;}
	.ft39{font-size:13px;font-family:Times;color:#ff0000;}
	.ft310{font-size:6px;font-family:Times;color:#211f21;}
	.ft311{font-size:13px;font-family:Times;color:#211f21;}
	.ft312{font-size:6px;font-family:Times;color:#211f21;}
	.ft313{font-size:13px;font-family:Times;color:#211f21;}
	.ft314{font-size:6px;font-family:Times;color:#211f21;}
	.ft315{font-size:11px;font-family:Times;color:#211f21;}
	.ft316{font-size:11px;font-family:Times;color:#211f21;}
	.ft317{font-size:5px;font-family:Times;color:#211f21;}
	.ft318{font-size:5px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page3-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft30">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft31">19577</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft30">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft32">the&#160;injected&#160;right&#160;half&#160;of&#160;the&#160;embryo&#160;was&#160;much&#160;dimmer,&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft32">indicating relative hyperpolarization compared to the&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft32">uninjected left side.&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft33"><b>Arch and&#160;<i>ChR2D156A</i></b><b>&#160;activities reduce&#160;<i>KRASG12D</i></b><b>-</b></p>
<p style="position:absolute;top:162px;left:87px;white-space:nowrap" class="ft33"><b>induced ITLS incidence</b></p>
<p style="position:absolute;top:197px;left:123px;white-space:nowrap" class="ft32">Co-injection&#160;&#160;of&#160;&#160;mRNAs&#160;&#160;for&#160;&#160;<i>KRASG12D</i>&#160;and either&#160;</p>
<p style="position:absolute;top:215px;left:87px;white-space:nowrap" class="ft36"><i>Arch</i>&#160;or&#160;<i>ChR2D156A&#160;</i>into one cell of a 16-cell stage embryo&#160;</p>
<p style="position:absolute;top:233px;left:87px;white-space:nowrap" class="ft32">resulted in the expression of the corresponding proteins&#160;</p>
<p style="position:absolute;top:251px;left:87px;white-space:nowrap" class="ft32">as&#160;&#160;early&#160;&#160;as&#160;&#160;4&#160;&#160;hours&#160;&#160;post&#160;&#160;injection&#160;&#160;(data&#160;&#160;not&#160;&#160;shown).&#160;</p>
<p style="position:absolute;top:269px;left:87px;white-space:nowrap" class="ft32">Embryos expressing light-activated ion channels were&#160;</p>
<p style="position:absolute;top:287px;left:87px;white-space:nowrap" class="ft32">exposed to light for 24 hours: arch-expressing embryos&#160;</p>
<p style="position:absolute;top:305px;left:87px;white-space:nowrap" class="ft32">were stimulated by green light, 555 nm, irradiance of&#160;&#160;</p>
<p style="position:absolute;top:323px;left:87px;white-space:nowrap" class="ft38">1&#160;&#160;mW/mm2&#160;for 500 ms followed by 1.5s in darkness,&#160;</p>
<p style="position:absolute;top:341px;left:87px;white-space:nowrap" class="ft32">while&#160;&#160;<i>ChR2D156A</i>-expressing cells were stimulated by&#160;</p>
<p style="position:absolute;top:359px;left:87px;white-space:nowrap" class="ft32">blue&#160;light:&#160;470&#160;nm&#160;light&#160;of&#160;2.4&#160;mW/mm2&#160;for 10 ms every&#160;&#160;</p>
<p style="position:absolute;top:377px;left:87px;white-space:nowrap" class="ft32">30&#160;&#160;seconds&#160;&#160;(Figure&#160;&#160;S2,&#160;&#160;3A;&#160;&#160;[48]).&#160;&#160;To&#160;&#160;study&#160;&#160;ITLS&#160;</p>
<p style="position:absolute;top:395px;left:87px;white-space:nowrap" class="ft32">prevention, embryos were exposed to the light beginning&#160;</p>
<p style="position:absolute;top:413px;left:87px;white-space:nowrap" class="ft32">four&#160;&#160;hours&#160;&#160;post&#160;&#160;injection,&#160;&#160;or,&#160;&#160;approximately&#160;&#160;stage&#160;&#160;9;&#160;</p>
<p style="position:absolute;top:431px;left:87px;white-space:nowrap" class="ft32">to induce normalization of tumors, exposure was from&#160;</p>
<p style="position:absolute;top:449px;left:87px;white-space:nowrap" class="ft32">stage 28 to stage 35.&#160;Two sets of controls were used for&#160;</p>
<p style="position:absolute;top:467px;left:87px;white-space:nowrap" class="ft32">comparison:&#160;embryos&#160;injected&#160;with&#160;only&#160;<i>KRASG12D</i>&#160;and&#160;</p>
<p style="position:absolute;top:485px;left:87px;white-space:nowrap" class="ft32">un-stimulated embryos expressing the oncogene and&#160;</p>
<p style="position:absolute;top:503px;left:87px;white-space:nowrap" class="ft32">either&#160;<i>Arch</i>&#160;or&#160;<i>ChR2D156A</i>&#160;(light&#160;by&#160;itself&#160;does&#160;not&#160;affect&#160;</p>
<p style="position:absolute;top:521px;left:87px;white-space:nowrap" class="ft32">V</p>
<p style="position:absolute;top:532px;left:98px;white-space:nowrap" class="ft310">mem&#160;of&#160;cells&#160;that&#160;do&#160;not&#160;express&#160;light-gated&#160;channels,&#160;</p>
<p style="position:absolute;top:539px;left:87px;white-space:nowrap" class="ft32">and tumor incidence does not vary among KRAS-only&#160;</p>
<p style="position:absolute;top:557px;left:87px;white-space:nowrap" class="ft32">injected&#160;embryos&#160;kept&#160;in&#160;dark,&#160;ambient&#160;light,&#160;or&#160;blue/red&#160;</p>
<p style="position:absolute;top:575px;left:87px;white-space:nowrap" class="ft32">optogenetic exposure [data not shown]).&#160;</p>
<p style="position:absolute;top:70px;left:523px;white-space:nowrap" class="ft32">Consistent&#160;&#160;with&#160;&#160;our&#160;&#160;previous&#160;&#160;finding&#160;&#160;that&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft32">hyperpolarization suppresses ITLS formation, our&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft32">experimental data show that&#160;<i>Arch</i>&#160;activity&#160;significantly&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft32">reduces the number of embryos that develop&#160;<i>KRASG12D</i>&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft32">ITLSs by 32% compared to&#160;<i>KRASG12D</i>-expressing embryos&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft32">lacking&#160;Arch&#160;(χ2&#160;=&#160;7.1,&#160;<i>p&#160;=&#160;</i>0.007)&#160;(Figure&#160;3B).&#160;Similarly,&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft32">the activity of&#160;<i>ChR2D156A</i>&#160;was&#160;able&#160;to&#160;significantly&#160;lower&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft36"><i>KRASG12D</i>&#160;ITLS&#160;incidence&#160;by&#160;31.4%&#160;(χ2&#160;= 6.8,&#160;<i>p =&#160;</i>0.009)&#160;&#160;</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft32">(Figure&#160;3B).&#160;Together, these data show that light-activated&#160;</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft36"><i>Arch</i>&#160;and&#160;<i>ChR2D156A</i>&#160;can reduce ITLS formation by&#160;</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft36"><i>KRASG12D</i>&#160;in non-excitable tissues, suggesting that light-</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft32">dependent activity of optogenetic reagents is a&#160;V</p>
<p style="position:absolute;top:280px;left:810px;white-space:nowrap" class="ft310">mem-</p>
<p style="position:absolute;top:286px;left:487px;white-space:nowrap" class="ft32">altering&#160;modality&#160;with&#160;efficacy&#160;in&#160;the&#160;suppression&#160;of&#160;ITLS&#160;</p>
<p style="position:absolute;top:304px;left:487px;white-space:nowrap" class="ft32">formation.</p>
<p style="position:absolute;top:340px;left:487px;white-space:nowrap" class="ft33"><b>Light-initiated&#160;<i>ChR2D156A</i></b><b>&#160;activity normalizes&#160;</b></p>
<p style="position:absolute;top:360px;left:487px;white-space:nowrap" class="ft33"><b>fully developed&#160;<i>KRASG12D&#160;</i></b><b>ITLSs</b></p>
<p style="position:absolute;top:395px;left:523px;white-space:nowrap" class="ft32">We next tested the utility of optogenetics in the&#160;</p>
<p style="position:absolute;top:413px;left:487px;white-space:nowrap" class="ft32">conversion of existing ITLSs into normal tissue. Similar to&#160;</p>
<p style="position:absolute;top:431px;left:487px;white-space:nowrap" class="ft32">the suppression experiments,&#160;<i>ChR2D156A</i>&#160;was co-expressed&#160;</p>
<p style="position:absolute;top:449px;left:487px;white-space:nowrap" class="ft32">with&#160;<i>KRASG12D</i>;&#160;in&#160;these&#160;experiments,&#160;however,&#160;stimulation&#160;</p>
<p style="position:absolute;top:467px;left:487px;white-space:nowrap" class="ft32">of the light-dependent channel was delayed until stages&#160;</p>
<p style="position:absolute;top:485px;left:487px;white-space:nowrap" class="ft32">between 28–35 when ITLSs were fully developed.&#160;</p>
<p style="position:absolute;top:503px;left:487px;white-space:nowrap" class="ft32">Tadpoles were then scored for presence or absence of&#160;</p>
<p style="position:absolute;top:521px;left:487px;white-space:nowrap" class="ft32">ITLSs when they reached stages 45–47 (Figure&#160;4A).&#160;</p>
<p style="position:absolute;top:539px;left:487px;white-space:nowrap" class="ft32">Stimulation of&#160;<i>ChR2D156A</i>-expressing cells within the&#160;</p>
<p style="position:absolute;top:557px;left:487px;white-space:nowrap" class="ft32">tumors resulted&#160;in 31% more embryos having normalized&#160;</p>
<p style="position:absolute;top:575px;left:487px;white-space:nowrap" class="ft32">their&#160;tumors&#160;–&#160;compared&#160;to&#160;their&#160;injected&#160;but&#160;un-stimulated&#160;</p>
<p style="position:absolute;top:955px;left:87px;white-space:nowrap" class="ft311"><b>Figure&#160;1: Optogenetic modulation of&#160;V</b></p>
<p style="position:absolute;top:967px;left:335px;white-space:nowrap" class="ft312"><b>mem&#160;to control ITLSs is achieved using a&#160;<i>KRAS</i></b></p>
<p style="position:absolute;top:957px;left:628px;white-space:nowrap" class="ft314"><i><b>G12D</b></i></p>
<p style="position:absolute;top:955px;left:649px;white-space:nowrap" class="ft311"><b>&#160;oncogene and light-sensitive&#160;</b></p>
<p style="position:absolute;top:973px;left:87px;white-space:nowrap" class="ft311"><b>ion channels in&#160;<i>Xenopus&#160;laevis</i></b><b>&#160;embryos.&#160;</b>(<b>A</b>)&#160;ITLSs&#160;were&#160;generated&#160;by&#160;injecting&#160;<i>KRASG12D</i>&#160;mRNA&#160;into a single blastomere&#160;of&#160;&#160;</p>
<p style="position:absolute;top:991px;left:87px;white-space:nowrap" class="ft31">16&#160;&#160;cell&#160;&#160;stage&#160;&#160;embryos.&#160;&#160;Injected&#160;&#160;embryos&#160;&#160;were&#160;&#160;raised&#160;&#160;in&#160;&#160;0.1&#160;&#160;×&#160;&#160;MMR&#160;&#160;before&#160;&#160;they&#160;&#160;were&#160;&#160;scored&#160;&#160;for&#160;&#160;the&#160;&#160;presence&#160;&#160;of&#160;&#160;ITLSs&#160;&#160;and&#160;&#160;imaged&#160;</p>
<p style="position:absolute;top:1008px;left:87px;white-space:nowrap" class="ft31">using&#160;&#160;bright&#160;&#160;field&#160;&#160;microscopy&#160;&#160;between&#160;&#160;stages&#160;&#160;28&#160;&#160;and&#160;&#160;35.&#160;&#160;(<b>B</b>) Schematic&#160;of optogenetic&#160;V</p>
<p style="position:absolute;top:1018px;left:589px;white-space:nowrap" class="ft318">mem&#160;modulation&#160;using a&#160;Channelrhodopsin-2&#160;</p>
<p style="position:absolute;top:1024px;left:87px;white-space:nowrap" class="ft31">mutant (<i>ChR2D156A</i>) channel:&#160;<i>ChR2D156A</i>&#160;mRNA&#160;was&#160;injected&#160;into&#160;1&#160;cell&#160;of&#160;a&#160;2-cell&#160;embryo,&#160;allowing&#160;the&#160;uninjected&#160;side&#160;to&#160;serve&#160;as&#160;an&#160;</p>
<p style="position:absolute;top:1040px;left:87px;white-space:nowrap" class="ft31">internal control. Embryos were raised to stage 18 in 0.1XMMR.&#160;(<b>C</b>)&#160;At stage 18, embryos were soaked in 1.9 µM&#160;DiBAC</p>
<p style="position:absolute;top:1050px;left:751px;white-space:nowrap" class="ft318">4(3) solution in&#160;</p>
<p style="position:absolute;top:1056px;left:87px;white-space:nowrap" class="ft31">0.1&#160;×&#160;MMR,&#160;and&#160;imaged&#160;using&#160;a&#160;DiBAC</p>
<p style="position:absolute;top:1066px;left:311px;white-space:nowrap" class="ft318">4&#160;(3)&#160;filter&#160;set&#160;(470/20;&#160;BS&#160;485;&#160;EM&#160;517/23).&#160;The&#160;un-injected&#160;left&#160;half&#160;of&#160;the&#160;embryo&#160;was&#160;highly&#160;</p>
<p style="position:absolute;top:1072px;left:87px;white-space:nowrap" class="ft31">fluorescent,&#160;indicating&#160;relative&#160;depolarization&#160;compared&#160;to&#160;the&#160;right&#160;half&#160;of&#160;the&#160;embryo,&#160;which&#160;is&#160;expressing&#160;<i>ChR2D156A</i>. Scale bar = 150 µm.&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>6fc8d60849732353c701eb07f0250484-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft40{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft41{font-size:11px;font-family:Times;color:#211f21;}
	.ft42{font-size:13px;font-family:Times;color:#211f21;}
	.ft43{font-size:6px;font-family:Times;color:#211f21;}
	.ft44{font-size:13px;font-family:Times;color:#211f21;}
	.ft45{font-size:6px;font-family:Times;color:#211f21;}
	.ft46{font-size:14px;font-family:Times;color:#211f21;}
	.ft47{font-size:7px;font-family:Times;color:#211f21;}
	.ft48{font-size:14px;font-family:Times;color:#211f21;}
	.ft49{font-size:16px;font-family:Times;color:#211f21;}
	.ft410{font-size:16px;font-family:Times;color:#211f21;}
	.ft411{font-size:13px;font-family:Times;color:#211f21;}
	.ft412{font-size:13px;font-family:Times;color:#211f21;}
	.ft413{font-size:11px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page4-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft40">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft41">19578</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft40">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:309px;left:87px;white-space:nowrap" class="ft42">counterparts&#160;(χ2&#160;= 8.6, *<i>p =&#160;</i>0.003) (Figure&#160;4B).&#160;These&#160;</p>
<p style="position:absolute;top:327px;left:87px;white-space:nowrap" class="ft42">results demonstrate that&#160;<i>ChR2D156A</i>&#160;increases the number&#160;</p>
<p style="position:absolute;top:345px;left:87px;white-space:nowrap" class="ft42">of oncogene-induced ITLSs that are normalized.</p>
<p style="position:absolute;top:363px;left:123px;white-space:nowrap" class="ft42">Moreover, optogenetic stimulation had a larger&#160;</p>
<p style="position:absolute;top:381px;left:87px;white-space:nowrap" class="ft42">effect&#160;than&#160;several&#160;drugs&#160;considered&#160;promising&#160;anti-tumor&#160;</p>
<p style="position:absolute;top:399px;left:87px;white-space:nowrap" class="ft42">therapies in human cancer medicine: the highly-selective&#160;</p>
<p style="position:absolute;top:417px;left:87px;white-space:nowrap" class="ft42">MEK&#160;1&#160;inhibitor&#160;Selumetinib;&#160;the&#160;potent&#160;Pi3K&#160;inhibitor&#160;</p>
<p style="position:absolute;top:435px;left:87px;white-space:nowrap" class="ft42">Pictillisib;&#160;and&#160;the&#160;inhibitor&#160;of&#160;oncogenic&#160;B-RAF&#160;kinase&#160;</p>
<p style="position:absolute;top:453px;left:87px;white-space:nowrap" class="ft42">activity&#160;Vemurafenib (grey bars, Figure&#160;4B).&#160;</p>
<p style="position:absolute;top:308px;left:487px;white-space:nowrap" class="ft46"><i><b>ChR2D156A</b></i><b>&#160;activity regulates muscle marker&#160;</b></p>
<p style="position:absolute;top:328px;left:487px;white-space:nowrap" class="ft48"><b>expression in KRAS-induced ITLSs&#160;</b></p>
<p style="position:absolute;top:363px;left:523px;white-space:nowrap" class="ft42">To determine whether there is a link between&#160;</p>
<p style="position:absolute;top:380px;left:487px;white-space:nowrap" class="ft44"><i>ChR2D156A</i>&#160;activation&#160;and&#160;the&#160;expressions&#160;of&#160;tumor-specific&#160;</p>
<p style="position:absolute;top:399px;left:487px;white-space:nowrap" class="ft42">transcriptional markers, we examined&#160;<i>chd15</i>&#160;(a satellite&#160;</p>
<p style="position:absolute;top:417px;left:487px;white-space:nowrap" class="ft42">cell marker expressed in differentiating myoblasts) and&#160;</p>
<p style="position:absolute;top:434px;left:487px;white-space:nowrap" class="ft44"><i>myod1</i>&#160;(a developing muscle cell marker expressed in&#160;</p>
<p style="position:absolute;top:453px;left:487px;white-space:nowrap" class="ft42">newly&#160;formed somites&#160;and&#160;involved&#160;in&#160;differentiation).&#160;</p>
<p style="position:absolute;top:76px;left:87px;white-space:nowrap" class="ft49"><b>Table 1: Ion concentrations in&#160;<i>Xenopus&#160;</i></b><b>embryonic cells and their&#160;medium (from [102])</b></p>
<p style="position:absolute;top:104px;left:167px;white-space:nowrap" class="ft411"><b>Ion</b></p>
<p style="position:absolute;top:104px;left:347px;white-space:nowrap" class="ft411"><b>External medium [mM]</b></p>
<p style="position:absolute;top:104px;left:644px;white-space:nowrap" class="ft411"><b>Intracellular&#160;[mM]</b></p>
<p style="position:absolute;top:130px;left:167px;white-space:nowrap" class="ft42">Na+</p>
<p style="position:absolute;top:130px;left:413px;white-space:nowrap" class="ft42">9.9</p>
<p style="position:absolute;top:130px;left:697px;white-space:nowrap" class="ft42">38</p>
<p style="position:absolute;top:156px;left:170px;white-space:nowrap" class="ft42">K+</p>
<p style="position:absolute;top:156px;left:413px;white-space:nowrap" class="ft42">0.2</p>
<p style="position:absolute;top:156px;left:697px;white-space:nowrap" class="ft42">51</p>
<p style="position:absolute;top:181px;left:165px;white-space:nowrap" class="ft42">Ca++</p>
<p style="position:absolute;top:181px;left:413px;white-space:nowrap" class="ft42">0.3</p>
<p style="position:absolute;top:181px;left:701px;white-space:nowrap" class="ft42">5</p>
<p style="position:absolute;top:206px;left:163px;white-space:nowrap" class="ft42">Mg++</p>
<p style="position:absolute;top:206px;left:413px;white-space:nowrap" class="ft42">0.2</p>
<p style="position:absolute;top:206px;left:697px;white-space:nowrap" class="ft42">12</p>
<p style="position:absolute;top:232px;left:170px;white-space:nowrap" class="ft42">H+</p>
<p style="position:absolute;top:232px;left:394px;white-space:nowrap" class="ft42">1.60E–05</p>
<p style="position:absolute;top:232px;left:676px;white-space:nowrap" class="ft42">1.80E–05</p>
<p style="position:absolute;top:257px;left:169px;white-space:nowrap" class="ft42">Cl–</p>
<p style="position:absolute;top:257px;left:410px;white-space:nowrap" class="ft42">11.1</p>
<p style="position:absolute;top:257px;left:697px;white-space:nowrap" class="ft42">30</p>
<p style="position:absolute;top:924px;left:87px;white-space:nowrap" class="ft411"><b>Figure&#160;2: Set up used to deliver&#160;spatio-temporally precise light stimulation of optogenetic ion-translocators expressed in&#160;</b></p>
<p style="position:absolute;top:942px;left:87px;white-space:nowrap" class="ft412"><i><b>Xenopus</b></i><b>&#160;embryo ITLSs.&#160;</b>We customized&#160;a Nikon&#160;AZ100 dissection&#160;scope for&#160;<i>in vivo</i>&#160;optogenetics&#160;[87]&#160;by&#160;replacing&#160;the&#160;epifluorescence&#160;</p>
<p style="position:absolute;top:960px;left:87px;white-space:nowrap" class="ft41">illumination&#160;source&#160;and&#160;light&#160;guide&#160;with&#160;a&#160;Spectra4&#160;LED&#160;illuminator&#160;connected&#160;to&#160;the&#160;scope&#160;via&#160;fiber&#160;optic&#160;cable&#160;(the&#160;black&#160;light&#160;guide&#160;</p>
<p style="position:absolute;top:976px;left:87px;white-space:nowrap" class="ft41">that&#160;passes in&#160;front&#160;of&#160;the&#160;vacuum&#160;source).&#160;The&#160;light&#160;is&#160;passed&#160;through&#160;a&#160;pinhole&#160;to&#160;set&#160;spot&#160;size&#160;diameter&#160;(located&#160;behind&#160;the&#160;oculars,&#160;not&#160;</p>
<p style="position:absolute;top:992px;left:87px;white-space:nowrap" class="ft41">visible&#160;in&#160;this&#160;image),&#160;then&#160;enters&#160;the&#160;scope&#160;and&#160;goes&#160;through&#160;an&#160;80/20&#160;splitter&#160;that&#160;allows&#160;the&#160;user&#160;to&#160;view&#160;the&#160;specimen&#160;on&#160;the&#160;monitor&#160;</p>
<p style="position:absolute;top:1008px;left:87px;white-space:nowrap" class="ft41">even&#160;while&#160;the&#160;LED&#160;is&#160;on.&#160;Finally,&#160;the&#160;light&#160;passes&#160;through&#160;the&#160;5&#160;×&#160;objective&#160;lens&#160;which&#160;further&#160;reduces&#160;spot&#160;diameter&#160;and&#160;aims&#160;the&#160;spot&#160;</p>
<p style="position:absolute;top:1025px;left:87px;white-space:nowrap" class="ft41">at&#160;the&#160;sample.&#160;An&#160;automated&#160;Ludl&#160;MAC6000&#160;XY&#160;stage&#160;(that&#160;can&#160;also&#160;be&#160;manipulated&#160;manually&#160;by&#160;a&#160;joystick)&#160;allows&#160;multiple&#160;embryos&#160;to&#160;</p>
<p style="position:absolute;top:1041px;left:87px;white-space:nowrap" class="ft41">be&#160;exposed&#160;repeatedly&#160;to&#160;the&#160;activating&#160;wavelength&#160;of&#160;light.&#160;Up&#160;to&#160;thirty&#160;embryos&#160;are&#160;loaded&#160;into&#160;a&#160;slide-mounted&#160;PDMS&#160;“chip”&#160;designed&#160;</p>
<p style="position:absolute;top:1057px;left:87px;white-space:nowrap" class="ft41">to&#160;use&#160;microfluidics&#160;to&#160;hold&#160;embryos&#160;in&#160;place&#160;[100];&#160;the&#160;chip&#160;is&#160;held&#160;to&#160;the&#160;slide&#160;by&#160;a&#160;vacuum&#160;and&#160;0.1&#160;×&#160;MMR&#160;is&#160;circulated&#160;by&#160;a&#160;peristaltic&#160;</p>
<p style="position:absolute;top:1073px;left:87px;white-space:nowrap" class="ft41">pump.&#160;The optogenetics components and the microscope are all controlled by NIS Elements.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>6fc8d60849732353c701eb07f0250484-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft50{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft51{font-size:11px;font-family:Times;color:#211f21;}
	.ft52{font-size:13px;font-family:Times;color:#211f21;}
	.ft53{font-size:13px;font-family:Times;color:#211f21;}
	.ft54{font-size:6px;font-family:Times;color:#211f21;}
	.ft55{font-size:13px;font-family:Times;color:#211f21;}
	.ft56{font-size:6px;font-family:Times;color:#211f21;}
	.ft57{font-size:13px;font-family:Times;color:#211f21;}
	.ft58{font-size:6px;font-family:Times;color:#211f21;}
	.ft59{font-size:11px;font-family:Times;color:#211f21;}
	.ft510{font-size:11px;font-family:Times;color:#211f21;}
	.ft511{font-size:5px;font-family:Times;color:#211f21;}
	.ft512{font-size:5px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page5-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft50">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft51">19579</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft50">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft52">We chose these two markers because the&#160;<i>KRASG12D&#160;</i></p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft52">induced rhabdomyosarcoma arises from skeletal muscle&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft52">tissue, and because these markers signal the presence&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft52">of rhabdomyosarcoma in human samples [79–81].&#160;As&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft52">expected from comparison with&#160;<i>KRASG12D</i>-induced human&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft52">tumors, ITLSs observed growing in a transgenic line of&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft52">animals&#160;that&#160;drive&#160;muscle-specific&#160;GFP&#160;fluorescence&#160;[82]&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft52">revealed&#160;the presence of ectopic muscle cells (Figure&#160;5).&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft52">Using&#160;qPCR,&#160;we&#160;next&#160;found&#160;that&#160;both&#160;muscle&#160;markers&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft52">were&#160;significantly&#160;up-regulated&#160;in&#160;tadpoles&#160;with&#160;<i>KRASG12D</i>&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft52">tumors&#160;&#160;(Figure&#160;&#160;6,&#160;&#160;green&#160;&#160;bars)&#160;&#160;compared&#160;&#160;to&#160;&#160;uninjected&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft52">controls&#160;(Figure&#160;6,&#160;blue&#160;bars);&#160;however,&#160;the&#160;expressions&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft52">of<i>&#160;myod1</i>&#160;and&#160;<i>cdh15</i>&#160;became&#160;normalized&#160;to&#160;control&#160;levels&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft52">when&#160;<i>ChR2D156A</i>&#160;was activated in tadpoles (Figure&#160;6, red&#160;</p>
<p style="position:absolute;top:907px;left:87px;white-space:nowrap" class="ft55"><b>Figure&#160;3: Expression of optogenetic channels&#160;Arch and&#160;ChR2D156A&#160;prior&#160;to ITLS&#160;appearance suppresses the formation&#160;</b></p>
<p style="position:absolute;top:925px;left:87px;white-space:nowrap" class="ft55"><b>of&#160;<i>KRASG12D</i></b><b>&#160;ITLSs.&#160;</b>(<b>A</b>) Schematic&#160;of experimental&#160;design for&#160;ITLS&#160;suppression: mRNAs for&#160;<i>KRASG12D&#160;</i>and&#160;<i>ChR2D156A</i>&#160;or&#160;<i>Arch</i>&#160;were&#160;</p>
<p style="position:absolute;top:943px;left:87px;white-space:nowrap" class="ft51">co-injected&#160;into&#160;a&#160;single&#160;blastomere&#160;of&#160;16-cell&#160;stage&#160;embryos;&#160;between&#160;4&#160;and&#160;28&#160;hours&#160;post&#160;injection&#160;(a&#160;total&#160;exposure&#160;of&#160;24&#160;hours),&#160;injected&#160;</p>
<p style="position:absolute;top:959px;left:87px;white-space:nowrap" class="ft51">embryos&#160;were&#160;exposed&#160;to&#160;580&#160;nm&#160;wavelength&#160;of&#160;light,&#160;1&#160;mw/mm2&#160;irradiance&#160;(stimulating&#160;<i>Arch</i>)&#160;or&#160;450&#160;nm&#160;wavelength&#160;of&#160;light&#160;with&#160;2.4&#160;mw/mm2&#160;&#160;</p>
<p style="position:absolute;top:976px;left:87px;white-space:nowrap" class="ft51">irradiance&#160;(stimulating<i>&#160;ChR2D156A</i>).&#160;<i>Arch</i>&#160;and&#160;<i>ChR2D156A</i>&#160;experiments were done separately to test the hypothesis that ITLS suppression is&#160;</p>
<p style="position:absolute;top:992px;left:87px;white-space:nowrap" class="ft51">due&#160;to&#160;changes&#160;in&#160;membrane&#160;voltage&#160;as&#160;opposed&#160;to&#160;channel&#160;or&#160;ion&#160;specific&#160;properties.&#160;Light-stimulated&#160;embryos&#160;were&#160;raised&#160;to&#160;stage&#160;35&#160;</p>
<p style="position:absolute;top:1008px;left:87px;white-space:nowrap" class="ft51">and&#160;scored&#160;for&#160;ITLSs&#160;to&#160;assess&#160;the&#160;efficacy&#160;of&#160;hyperpolarizing&#160;optogenetic&#160;channels&#160;as&#160;ITLS&#160;suppressing&#160;reagents.&#160;(<b>B</b>)&#160;The&#160;two different&#160;</p>
<p style="position:absolute;top:1024px;left:87px;white-space:nowrap" class="ft51">hyperpolarizing&#160;translocators – based on active&#160;pumping of H+&#160;(<i>Arch</i>) and passive diffusion of positive, monovalent&#160;cations (<i>ChR2D156A</i>) – both&#160;&#160;</p>
<p style="position:absolute;top:1040px;left:87px;white-space:nowrap" class="ft51">resulted in suppression of ITLSs, demonstrating&#160;that this effect is likely&#160;due to a change in&#160;V</p>
<p style="position:absolute;top:1051px;left:584px;white-space:nowrap" class="ft512">mem&#160;and is not tied to one channel&#160;protein. 32%&#160;</p>
<p style="position:absolute;top:1057px;left:87px;white-space:nowrap" class="ft51">and 31% fewer embryos with ITLS were observed among&#160;<i>Arch</i>&#160;and&#160;<i>ChR2D156A</i>&#160;injected&#160;embryos,&#160;respectively&#160;(<i>Arch</i>: c2&#160;= 7.1, *<i>p&#160;=&#160;</i>0.007;&#160;&#160;</p>
<p style="position:absolute;top:1073px;left:87px;white-space:nowrap" class="ft510"><i>ChR2D156A</i>: χ2&#160;= 6.8, *<i>p =&#160;</i>0.009. χ2&#160;values are for comparisons of ITLS incidence in light stimulated versus un-stimulated embryos).&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>6fc8d60849732353c701eb07f0250484-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft60{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft61{font-size:11px;font-family:Times;color:#211f21;}
	.ft62{font-size:13px;font-family:Times;color:#211f21;}
	.ft63{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft64{font-size:13px;font-family:Times;color:#211f21;}
	.ft65{font-size:13px;font-family:Times;color:#211f21;}
	.ft66{font-size:13px;font-family:Times;color:#211f21;}
	.ft67{font-size:6px;font-family:Times;color:#211f21;}
	.ft68{font-size:11px;font-family:Times;color:#211f21;}
	.ft69{font-size:11px;font-family:Times;color:#211f21;}
	.ft610{font-size:5px;font-family:Times;color:#211f21;}
	.ft611{font-size:5px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page6-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft60">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft61">19580</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft60">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft62">bars).&#160;Taken together, these data show that optogenetic&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft62">modulation&#160;of&#160;ion&#160;flux&#160;and&#160;resting&#160;potential&#160;reduces&#160;the&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft62">expression of tumor markers as well as normalizes the&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft62">tissue structure.</p>
<p style="position:absolute;top:161px;left:87px;white-space:nowrap" class="ft63"><b>DISCUSSION</b></p>
<p style="position:absolute;top:200px;left:123px;white-space:nowrap" class="ft62">Given the instructive role of bioelectric parameters&#160;</p>
<p style="position:absolute;top:218px;left:87px;white-space:nowrap" class="ft62">in orchestrating cell behavior towards adaptive pattern&#160;</p>
<p style="position:absolute;top:236px;left:87px;white-space:nowrap" class="ft62">formation [53, 83–85], our lab is interested in using&#160;</p>
<p style="position:absolute;top:254px;left:87px;white-space:nowrap" class="ft62">modulation of resting potential&#160;<i>in vivo</i>&#160;as an approach&#160;</p>
<p style="position:absolute;top:272px;left:87px;white-space:nowrap" class="ft62">to understanding misregulation of developmental&#160;</p>
<p style="position:absolute;top:290px;left:87px;white-space:nowrap" class="ft62">signaling as occurs in cancer, birth defects, and other&#160;</p>
<p style="position:absolute;top:308px;left:87px;white-space:nowrap" class="ft62">disease&#160;conditions.&#160;Previous&#160;work&#160;has&#160;shown&#160;that&#160;tumor-</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft62">like structures induced in&#160;<i>Xenopus laevis</i>&#160;embryos by&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft62">mammalian oncogenes (Figure&#160;1A) exhibit many of&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft62">the&#160;properties&#160;of&#160;tumors:&#160;overproliferation,&#160;expression&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft62">of&#160;known&#160;tumor&#160;markers,&#160;attraction&#160;of&#160;vasculature,&#160;and&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft62">histological disorganization [3, 40].&#160;They also possess&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft62">a&#160;&#160;depolarized&#160;&#160;potential&#160;&#160;relative&#160;&#160;to&#160;&#160;adjacent&#160;&#160;cells&#160;&#160;that&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft62">are&#160;not part of the&#160;ITLS – a property&#160;long-known to be&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft62">associated with cancer cells [24, 86], that was recently&#160;</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft62">shown&#160;to&#160;be&#160;an&#160;instructive&#160;factor,&#160;not&#160;merely&#160;a&#160;read-out;&#160;</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft62">actively preventing this depolarization can prevent the&#160;</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft62">appearance of ITLSs [4]. In this study, we extend our&#160;</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft62">ability&#160;to&#160;control&#160;tumorigenic&#160;pathways&#160;by&#160;expanding&#160;the&#160;</p>
<p style="position:absolute;top:286px;left:487px;white-space:nowrap" class="ft62">use&#160;of&#160;optogenetics&#160;to&#160;this&#160;new&#160;system,&#160;and&#160;we&#160;exploit&#160;the&#160;</p>
<p style="position:absolute;top:304px;left:487px;white-space:nowrap" class="ft62">temporal and cellular resolution afforded by light-gated&#160;</p>
<p style="position:absolute;top:973px;left:87px;white-space:nowrap" class="ft65"><b>Figure&#160;4:&#160;After&#160;ITLS&#160;formation, activation of&#160;<i>ChR2D156A</i></b><b>&#160;normalizes&#160;<i>KRASG12D</i></b><b>&#160;ITLSs.&#160;</b>(<b>A</b>) Schematic&#160;of experimental&#160;design&#160;</p>
<p style="position:absolute;top:991px;left:87px;white-space:nowrap" class="ft61">for ITLS&#160;normalization:&#160;<i>ChR2D156A</i>&#160;expressing&#160;embryos&#160;(stages&#160;28–35) with&#160;<i>KRASG12D&#160;</i>ITLSs&#160;were&#160;subjected&#160;to&#160;450&#160;nm&#160;wavelength&#160;of&#160;</p>
<p style="position:absolute;top:1008px;left:87px;white-space:nowrap" class="ft61">light&#160;with&#160;irradiance&#160;of&#160;0.5&#160;mw/mm2.&#160;Light-stimulated&#160;embryos&#160;were&#160;raised&#160;to&#160;stage&#160;45–47&#160;and&#160;scored&#160;for&#160;ITLSs&#160;to&#160;assess the&#160;ability&#160;of&#160;</p>
<p style="position:absolute;top:1024px;left:87px;white-space:nowrap" class="ft61">optogenetic&#160;V</p>
<p style="position:absolute;top:1034px;left:162px;white-space:nowrap" class="ft611">mem&#160;modulation&#160;to normalize&#160;ITLSs. (<b>B</b>) Light activation&#160;of&#160;<i>ChR2</i></p>
<p style="position:absolute;top:1025px;left:511px;white-space:nowrap" class="ft610"><i>D156A</i></p>
<p style="position:absolute;top:1024px;left:533px;white-space:nowrap" class="ft61">&#160;in ITLSs (blue bar) resulted in 31% more embryos with&#160;</p>
<p style="position:absolute;top:1040px;left:87px;white-space:nowrap" class="ft61">normalized&#160;ITLSs&#160;compared&#160;to&#160;their&#160;un-stimulated&#160;counterparts&#160;(red&#160;bar)&#160;(χ2&#160;= 8.6, *<i>p =&#160;</i>0.003). By comparison, treatment&#160;with the highly-</p>
<p style="position:absolute;top:1056px;left:87px;white-space:nowrap" class="ft61">selective&#160;MEK&#160;1&#160;inhibitor&#160;(Selumetinib),&#160;a&#160;potent&#160;PI3K&#160;inhibitor&#160;(Pictillisib),&#160;or&#160;a&#160;potent&#160;inhibitor&#160;of&#160;oncogenic&#160;B-RAF&#160;kinase&#160;activity&#160;</p>
<p style="position:absolute;top:1072px;left:87px;white-space:nowrap" class="ft61">(Vemurafenib), resulted in the same&#160;<i>KRASG12D</i>&#160;tumor incidence as in the unstimulated control.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>6fc8d60849732353c701eb07f0250484-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft70{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft71{font-size:11px;font-family:Times;color:#211f21;}
	.ft72{font-size:13px;font-family:Times;color:#211f21;}
	.ft73{font-size:13px;font-family:Times;color:#211f21;}
	.ft74{font-size:6px;font-family:Times;color:#211f21;}
	.ft75{font-size:6px;font-family:Times;color:#211f21;}
	.ft76{font-size:13px;font-family:Times;color:#211f21;}
	.ft77{font-size:13px;font-family:Times;color:#211f21;}
	.ft78{font-size:6px;font-family:Times;color:#211f21;}
	.ft79{font-size:11px;font-family:Times;color:#211f21;}
	.ft710{font-size:5px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page7-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft70">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft71">19581</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft70">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft72">ion channels to remove ITLSs after they have already been&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft72">formed.</p>
<p style="position:absolute;top:106px;left:123px;white-space:nowrap" class="ft72">We have previously demonstrated the functionality&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft72">of&#160;&#160;<i>Arch</i>&#160;in&#160;<i>Xenopus</i>&#160;embryonic and larval tissue: light&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft72">activation of this hyperpolarizing H+&#160;pump restores tail&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft72">regeneration&#160;capability&#160;at&#160;non-regenerative&#160;stages [49].&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft72">Here,&#160;we&#160;show&#160;that&#160;light&#160;activation&#160;of&#160;another&#160;light-gated&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft72">channel (<i>ChR2D156A</i>) also induces hyperpolarization in non-</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft72">excitable&#160;&#160;<i>Xenopus</i>&#160;cells (Figure&#160;1C).&#160;This differs from&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft72">mammalian neurons where high Na+&#160;concentration in&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft72">the&#160;medium&#160;favors&#160;influx&#160;of&#160;the&#160;cation&#160;through&#160;channels,&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft72">resulting&#160;&#160;in&#160;&#160;depolarization;&#160;&#160;<i>Xenopus</i>&#160;embryos grow in&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft72">very-low extracellular Na+&#160;medium, thus opening of cation&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft72">channels results in hyperpolarization [87].&#160;</p>
<p style="position:absolute;top:322px;left:123px;white-space:nowrap" class="ft72">Channelrhodopsin variant D156A&#160;was chosen&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft72">because&#160;of many&#160;optogenetic constructs&#160;tested&#160;[48] it&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft72">caused the fewest unwanted side effects on embryogenesis.&#160;</p>
<p style="position:absolute;top:376px;left:87px;white-space:nowrap" class="ft72">While ChR2 does exhibit some desensitization under&#160;</p>
<p style="position:absolute;top:394px;left:87px;white-space:nowrap" class="ft72">illumination,&#160;this&#160;was&#160;not&#160;a&#160;problem&#160;in&#160;this&#160;application&#160;</p>
<p style="position:absolute;top:412px;left:87px;white-space:nowrap" class="ft72">because high spiking rates are not used to encode&#160;</p>
<p style="position:absolute;top:430px;left:87px;white-space:nowrap" class="ft72">information&#160;in&#160;this kind of&#160;developmental bioelectricity&#160;</p>
<p style="position:absolute;top:448px;left:87px;white-space:nowrap" class="ft72">context [45]. Moreover, exposure of&#160;<i>ChR2D156A</i>&#160;was&#160;</p>
<p style="position:absolute;top:466px;left:87px;white-space:nowrap" class="ft72">limited to 10 ms pulses, followed by 30s of darkness, i.e.&#160;</p>
<p style="position:absolute;top:484px;left:87px;white-space:nowrap" class="ft72">a regimen than minimizes desensitization [88] and the&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft72">shift away from a mixture of positive cations to primarily&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft72">proton&#160;flux&#160;[89].&#160;Thus,&#160;we&#160;are&#160;confident&#160;that&#160;stimulation&#160;of&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft73"><i>ChR2D156A</i>&#160;led to the hyperpolarization we measured due to&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft72">efflux&#160;of&#160;a&#160;mixture&#160;of&#160;positive&#160;cations.&#160;We&#160;found&#160;that&#160;the&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft72">surface expression of&#160;<i>Arch</i>&#160;and&#160;<i>ChR2D156A</i>&#160;coupled with the&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft72">non-toxic,&#160;high&#160;temporal-resolution&#160;light&#160;regimen,&#160;makes&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft72">the&#160;optogenetic&#160;approach&#160;(Figure&#160;2)&#160;suitable&#160;for&#160;targeting&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft72">tumorigenesis&#160;<i>in vivo</i>.&#160;</p>
<p style="position:absolute;top:214px;left:523px;white-space:nowrap" class="ft72">We&#160;successfully exploited&#160;light-induced&#160;</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft72">hyperpolarization of&#160;<i>Arch</i>&#160;expressing cells to decrease&#160;</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft72">ITLS&#160;incidence&#160;among&#160;embryos&#160;expressing&#160;the&#160;<i>KRASG12D</i>&#160;</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft72">oncogene (Figure&#160;3A, 3B). Importantly, compared to&#160;</p>
<p style="position:absolute;top:286px;left:487px;white-space:nowrap" class="ft72">expressing constitutively-open hyperpolarizing channels,&#160;</p>
<p style="position:absolute;top:304px;left:487px;white-space:nowrap" class="ft72">the&#160;light regimen was&#160;delivered for&#160;only&#160;24 hours, was&#160;</p>
<p style="position:absolute;top:322px;left:487px;white-space:nowrap" class="ft72">temporally more precise and convenient, and the technique&#160;</p>
<p style="position:absolute;top:340px;left:487px;white-space:nowrap" class="ft72">is equally effective at suppressing ITLSs.&#160;To rule out&#160;</p>
<p style="position:absolute;top:358px;left:487px;white-space:nowrap" class="ft72">any Arch&#160;H+-pump-specific&#160;&#160;ITLS&#160;&#160;suppression&#160;&#160;effects,&#160;</p>
<p style="position:absolute;top:376px;left:487px;white-space:nowrap" class="ft72">we&#160;also&#160;employed&#160;light activation&#160;of&#160;the&#160;<i>ChR2D156A</i>&#160;non-</p>
<p style="position:absolute;top:394px;left:487px;white-space:nowrap" class="ft72">specific&#160;cation&#160;channel&#160;in&#160;similar&#160;experiments&#160;(Figure&#160;3A),&#160;</p>
<p style="position:absolute;top:412px;left:487px;white-space:nowrap" class="ft72">thereby generating hyperpolarizing current by a different&#160;</p>
<p style="position:absolute;top:430px;left:487px;white-space:nowrap" class="ft72">protein&#160;and&#160;a&#160;different&#160;mechanism,&#160;finding&#160;that&#160;passive&#160;</p>
<p style="position:absolute;top:448px;left:487px;white-space:nowrap" class="ft72">cation&#160;efflux,&#160;like&#160;active&#160;H+-efflux,&#160;reduced&#160;the&#160;number&#160;</p>
<p style="position:absolute;top:466px;left:487px;white-space:nowrap" class="ft72">of&#160;embryos with&#160;<i>KRASG12D</i>-induced ITLSs&#160;(Figure&#160;3B).&#160;</p>
<p style="position:absolute;top:484px;left:487px;white-space:nowrap" class="ft72">The results obtained using the two distinct optogenetic&#160;</p>
<p style="position:absolute;top:1004px;left:87px;white-space:nowrap" class="ft76"><b>Figure 5: Muscle specific expression of GFP3 controlled by the cardiac actin (Car) promoter is present in <i>KRASG12D&#160;</i></b></p>
<p style="position:absolute;top:1022px;left:87px;white-space:nowrap" class="ft77"><i><b>ITLS.&#160;</b></i>Tadpoles&#160;injected&#160;with&#160;Tol2-CarPr-GFP3&#160;[101]&#160;at&#160;the&#160;2-cell&#160;stage&#160;display&#160;normal&#160;muscle&#160;specific&#160;localization&#160;of&#160;GFP3&#160;within&#160;</p>
<p style="position:absolute;top:1040px;left:87px;white-space:nowrap" class="ft71">the&#160;somites&#160;(A, A’, A”&#160;showing&#160;transmitted&#160;light,&#160;GFP&#160;fluorescence,&#160;and&#160;both,&#160;respectively).&#160;In&#160;contrast,&#160;Tol2-CarPr-GFP3&#160;tadpoles&#160;also&#160;</p>
<p style="position:absolute;top:1056px;left:87px;white-space:nowrap" class="ft71">injected&#160;with&#160;<i>KRASG12D</i>&#160;reveal&#160;a&#160;strong&#160;GFP3&#160;signal&#160;in&#160;ITLS’s,&#160;confirming&#160;the&#160;presence&#160;of&#160;ectopic&#160;muscle&#160;in&#160;the&#160;KRAS-induced&#160;tumor-like&#160;</p>
<p style="position:absolute;top:1072px;left:87px;white-space:nowrap" class="ft71">structures.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>6fc8d60849732353c701eb07f0250484-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft80{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft81{font-size:11px;font-family:Times;color:#211f21;}
	.ft82{font-size:13px;font-family:Times;color:#211f21;}
	.ft83{font-size:6px;font-family:Times;color:#211f21;}
	.ft84{font-size:13px;font-family:Times;color:#211f21;}
	.ft85{font-size:13px;font-family:Times;color:#211f21;}
	.ft86{font-size:13px;font-family:Times;color:#211f21;}
	.ft87{font-size:6px;font-family:Times;color:#211f21;}
	.ft88{font-size:11px;font-family:Times;color:#211f21;}
	.ft89{font-size:5px;font-family:Times;color:#211f21;}
	.ft810{font-size:5px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page8-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft80">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft81">19582</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft80">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft82">channels&#160;that&#160;are&#160;not&#160;restricted&#160;to&#160;one&#160;type&#160;of&#160;ion&#160;flux,&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft82">are&#160;consistent&#160;with&#160;V</p>
<p style="position:absolute;top:100px;left:227px;white-space:nowrap" class="ft83">mem&#160;&#160;<i>per&#160;se</i>&#160;being&#160;the&#160;instructive&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft82">factor in regulating oncogene-mediated tumorigenesis&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft82">[4,&#160;10].&#160;We&#160;also&#160;demonstrate&#160;for&#160;the&#160;first&#160;time&#160;that&#160;light-</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft82">gated channels expressed in cells of tadpoles with KRAS&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft82">ITLSs can be non-invasively activated for a duration&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft82">sufficient&#160;&#160;to&#160;&#160;significantly&#160;&#160;increase&#160;&#160;the&#160;&#160;frequency&#160;&#160;of&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft82">ITLS&#160;&#160;normalization,&#160;&#160;an&#160;&#160;exciting&#160;&#160;finding&#160;&#160;suggesting&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft82">the possibility of remission-induction in addition to&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft82">prevention (Figure&#160;3, 4). Moreover, we show that the&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft82">performance&#160;of&#160;this&#160;non-invasive&#160;optogenetic&#160;stimulation&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft82">is&#160;superior&#160;to&#160;other&#160;anti-tumor&#160;agents&#160;we&#160;tested,&#160;including&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft82">those that have been shown to be promising in human&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft82">cancer medicine: Selumetinib, a highly-selective MEK&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft82">1&#160;&#160;inhibitor;&#160;&#160;Pictillisib,&#160;&#160;a&#160;&#160;potent&#160;&#160;Pi3K&#160;&#160;inhibitor;&#160;&#160;and&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft82">Vemurafenib, a potent inhibitor of oncogenic B-RAF&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft82">kinase&#160;activity,&#160;(grey&#160;bars,&#160;Figure&#160;4B).&#160;While&#160;these&#160;are&#160;</p>
<p style="position:absolute;top:376px;left:87px;white-space:nowrap" class="ft82">the&#160;&#160;first&#160;&#160;data&#160;&#160;testing&#160;&#160;these&#160;&#160;compounds&#160;&#160;in&#160;&#160;the&#160;&#160;Xenopus&#160;</p>
<p style="position:absolute;top:394px;left:87px;white-space:nowrap" class="ft82">tumor assay, we cannot rule out that subsequent research&#160;</p>
<p style="position:absolute;top:412px;left:87px;white-space:nowrap" class="ft82">could identify a treatment regime that would allow these&#160;</p>
<p style="position:absolute;top:430px;left:87px;white-space:nowrap" class="ft82">compounds to be more efficacious.</p>
<p style="position:absolute;top:70px;left:523px;white-space:nowrap" class="ft82">Our&#160;qPCR&#160;data&#160;(Figure&#160;6)&#160;indicate&#160;that&#160;light-induced&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft82">hyperpolarization of tumors also involves normalization&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft82">of the expression of tumor markers, although it must be&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft82">kept&#160;in&#160;mind&#160;that&#160;mRNA&#160;data&#160;do&#160;not&#160;necessarily&#160;reflect&#160;a&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft82">linear correspondence to the presence of protein.&#160;Together,&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft82">the data show&#160;that manipulation&#160;of bioelectric&#160;cell state, a&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft82">powerful, tractable regulator of cancer cell normalization&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft82">and reprogramming, is possible using optogenetics, thus&#160;</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft82">introducing a new class of biomedical strategies for tumor&#160;</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft82">treatment.&#160;The recent development of pharmacological&#160;</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft82">approaches&#160;to&#160;render&#160;existing&#160;ion&#160;channels&#160;light-sensitive&#160;</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft82">[90–92] suggests a next-generation approach that would&#160;</p>
<p style="position:absolute;top:286px;left:487px;white-space:nowrap" class="ft82">not require introduction of transgenes (optogenetic&#160;</p>
<p style="position:absolute;top:304px;left:487px;white-space:nowrap" class="ft82">channels) into the target tissue.</p>
<p style="position:absolute;top:322px;left:523px;white-space:nowrap" class="ft82">In&#160;&#160;summary,&#160;&#160;we&#160;&#160;report&#160;&#160;here&#160;&#160;the&#160;&#160;first&#160;&#160;use&#160;&#160;of&#160;</p>
<p style="position:absolute;top:340px;left:487px;white-space:nowrap" class="ft82">optogenetics as a temporally precise regulator of&#160;V</p>
<p style="position:absolute;top:352px;left:799px;white-space:nowrap" class="ft83">mem&#160;to&#160;</p>
<p style="position:absolute;top:358px;left:487px;white-space:nowrap" class="ft82">suppress and normalize oncogene-induced ITLSs. More&#160;</p>
<p style="position:absolute;top:376px;left:487px;white-space:nowrap" class="ft82">broadly, this tool will advance the study of resting potential&#160;</p>
<p style="position:absolute;top:394px;left:487px;white-space:nowrap" class="ft82">as another&#160;important&#160;component&#160;of the microenvironment&#160;</p>
<p style="position:absolute;top:412px;left:487px;white-space:nowrap" class="ft82">that is so crucial for cancer initiation and progression&#160;</p>
<p style="position:absolute;top:430px;left:487px;white-space:nowrap" class="ft82">[93–97]. Our implementation of light-gated bioelectrical&#160;</p>
<p style="position:absolute;top:1022px;left:87px;white-space:nowrap" class="ft85"><b>Figure&#160;6: Light activation&#160;of&#160;<i>ChR2D156A</i></b><b>&#160;results in downregulated expression of ectopic&#160;muscle markers.&#160;</b>Human tumors&#160;</p>
<p style="position:absolute;top:1040px;left:87px;white-space:nowrap" class="ft81">associated&#160;with&#160;KRAS&#160;mutations&#160;express&#160;the&#160;muscle&#160;markers&#160;myod1&#160;and&#160;cdh15.&#160;Using&#160;qPCR&#160;(see&#160;Methods&#160;for&#160;details),&#160;we&#160;found&#160;that&#160;</p>
<p style="position:absolute;top:1057px;left:87px;white-space:nowrap" class="ft81">expression&#160;of myod1&#160;and&#160;cdh15&#160;was likewise&#160;up-regulated&#160;in&#160;tadpoles&#160;with&#160;<i>KRASG12D</i>-induced&#160;ITLSs. Moreover, activation&#160;of&#160;<i>ChR2D156A</i>&#160;</p>
<p style="position:absolute;top:1073px;left:87px;white-space:nowrap" class="ft81">in these tadpoles significantly lowered myod1 and cdh15 expressions, down to baseline levels (χ2&#160;test compared to controls, *<i>p &lt;</i>&#160;0.01).</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>6fc8d60849732353c701eb07f0250484-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft90{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft91{font-size:11px;font-family:Times;color:#211f21;}
	.ft92{font-size:13px;font-family:Times;color:#211f21;}
	.ft93{font-size:13px;font-family:Times;color:#211f21;}
	.ft94{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft95{font-size:14px;font-family:Times;color:#211f21;}
	.ft96{font-size:6px;font-family:Times;color:#211f21;}
	.ft97{font-size:6px;font-family:Times;color:#211f21;}
	.ft98{font-size:7px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page9-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft90">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft91">19583</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft90">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft92">signaling&#160;<i>in vivo</i>&#160;highlights another opportunity for the&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft92">optogenetic&#160;toolbox&#160;to&#160;extend&#160;beyond&#160;excitable&#160;cells.&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft92">Moreover, our data suggest a light-based therapeutics&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft92">strategy that couples gene therapy with optogenetics to&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft92">counteract tumorigenesis and promote regression&#160;<i>in vivo</i>.&#160;</p>
<p style="position:absolute;top:179px;left:87px;white-space:nowrap" class="ft94"><b>MATERIALS AND&#160;METHODS</b></p>
<p style="position:absolute;top:218px;left:87px;white-space:nowrap" class="ft95"><b>Animal husbandry&#160;</b></p>
<p style="position:absolute;top:252px;left:123px;white-space:nowrap" class="ft93"><i>Xenopus laevis&#160;</i>eggs were fertilized&#160;<i>in vitro</i>, and&#160;</p>
<p style="position:absolute;top:271px;left:87px;white-space:nowrap" class="ft92">embryos were cultured according to standard protocols&#160;</p>
<p style="position:absolute;top:289px;left:87px;white-space:nowrap" class="ft92">[98],&#160;in&#160;0.1&#160;×&#160;Modified&#160;Marc’s&#160;Ringers&#160;(MMR;&#160;pH&#160;7.8)&#160;</p>
<p style="position:absolute;top:307px;left:87px;white-space:nowrap" class="ft92">with&#160;0.1%&#160;Gentamicin.&#160;<i>Xenopus&#160;</i>embryos&#160;were&#160;housed&#160;at&#160;</p>
<p style="position:absolute;top:325px;left:87px;white-space:nowrap" class="ft92">14–18°C and staged according to Nieuwkoop and Faber&#160;</p>
<p style="position:absolute;top:343px;left:87px;white-space:nowrap" class="ft92">[99].&#160;All experimental procedures involving the use of&#160;</p>
<p style="position:absolute;top:361px;left:87px;white-space:nowrap" class="ft92">animals for experimental purposes were approved by the&#160;</p>
<p style="position:absolute;top:379px;left:87px;white-space:nowrap" class="ft92">Institutional&#160;Animal Care and Use Committees (IACUC)&#160;</p>
<p style="position:absolute;top:397px;left:87px;white-space:nowrap" class="ft92">and&#160;Tufts University Department of Lab&#160;Animal Medicine&#160;</p>
<p style="position:absolute;top:415px;left:87px;white-space:nowrap" class="ft92">(DLAM) under the protocol number M2014–79.&#160;</p>
<p style="position:absolute;top:451px;left:87px;white-space:nowrap" class="ft95"><b>Microinjection</b></p>
<p style="position:absolute;top:486px;left:123px;white-space:nowrap" class="ft92">Fertilized<i>&#160;Xenopus</i>&#160;embryos were transferred into&#160;</p>
<p style="position:absolute;top:504px;left:87px;white-space:nowrap" class="ft92">mesh-bottomed&#160;dishes&#160;with&#160;3%&#160;Ficoll&#160;and&#160;injected&#160;with&#160;</p>
<p style="position:absolute;top:522px;left:87px;white-space:nowrap" class="ft92">capped, synthetic mRNAs (made using the&#160;Ambion&#160;</p>
<p style="position:absolute;top:540px;left:87px;white-space:nowrap" class="ft92">Message Machine kit) dissolved in water at the stages&#160;</p>
<p style="position:absolute;top:558px;left:87px;white-space:nowrap" class="ft92">indicated.&#160;The doses per cell were&#160;<i>KRASG12D</i>&#160;[71]&#160;40pg;&#160;</p>
<p style="position:absolute;top:575px;left:87px;white-space:nowrap" class="ft93"><i>Arch</i>&#160;[69],&#160;60pg;&#160;and&#160;<i>ChR2D156A</i>&#160;[72] 50pg.&#160;Two hours after&#160;</p>
<p style="position:absolute;top:594px;left:87px;white-space:nowrap" class="ft92">injection,&#160;embryos&#160;were&#160;transferred&#160;into&#160;0.75&#160;×&#160;MMR&#160;for&#160;</p>
<p style="position:absolute;top:612px;left:87px;white-space:nowrap" class="ft92">45&#160;minutes&#160;before&#160;they&#160;were&#160;washed&#160;and&#160;cultured&#160;in&#160;0.1&#160;×&#160;&#160;</p>
<p style="position:absolute;top:630px;left:87px;white-space:nowrap" class="ft92">MMR&#160;until&#160;desired&#160;stage&#160;was&#160;reached.&#160;Injected&#160;embryos&#160;</p>
<p style="position:absolute;top:648px;left:87px;white-space:nowrap" class="ft92">were stimulated with the appropriate wavelength of light&#160;</p>
<p style="position:absolute;top:666px;left:87px;white-space:nowrap" class="ft92">and irradiance before or after ITLSs fully form (stages&#160;</p>
<p style="position:absolute;top:684px;left:87px;white-space:nowrap" class="ft92">28–35). Embryos were scored for the presence of ITLSs&#160;</p>
<p style="position:absolute;top:702px;left:87px;white-space:nowrap" class="ft92">using bright field microscopy as described in [3, 41, 42].</p>
<p style="position:absolute;top:737px;left:87px;white-space:nowrap" class="ft95"><b>Light stimulation</b></p>
<p style="position:absolute;top:772px;left:123px;white-space:nowrap" class="ft92">During&#160;ITLS&#160;suppression&#160;experiments, an&#160;</p>
<p style="position:absolute;top:790px;left:87px;white-space:nowrap" class="ft92">optogenetic set up (Figure&#160;2) was used so that each&#160;</p>
<p style="position:absolute;top:808px;left:87px;white-space:nowrap" class="ft92">embryo,&#160;&#160;in&#160;&#160;a&#160;&#160;microfluidic&#160;&#160;chip&#160;&#160;placed&#160;&#160;on&#160;&#160;a&#160;&#160;motorized&#160;</p>
<p style="position:absolute;top:826px;left:87px;white-space:nowrap" class="ft92">stage, individually received a light regimen with the&#160;</p>
<p style="position:absolute;top:844px;left:87px;white-space:nowrap" class="ft92">following&#160;parameters:&#160;<i>Arch</i>&#160;–&#160;580&#160;nm&#160;wavelength,&#160;1&#160;mw/</p>
<p style="position:absolute;top:862px;left:87px;white-space:nowrap" class="ft92">mm2&#160;irradiance,&#160;500&#160;ms&#160;on,&#160;1.50s&#160;off;&#160;<i>Ch2R</i></p>
<p style="position:absolute;top:873px;left:362px;white-space:nowrap" class="ft96"><i>(D156A)</i>&#160;– 450&#160;</p>
<p style="position:absolute;top:880px;left:87px;white-space:nowrap" class="ft92">nm&#160;wavelength,&#160;2.4&#160;mw/mm2&#160;irradiance, 10 ms on, 30s off.&#160;</p>
<p style="position:absolute;top:898px;left:87px;white-space:nowrap" class="ft92">For&#160;normalization&#160;experiments involving Ch2R (D156A),&#160;</p>
<p style="position:absolute;top:916px;left:87px;white-space:nowrap" class="ft92">a petridish of embryos with&#160;<i>KRASG12D</i>&#160;ITLS were placed&#160;</p>
<p style="position:absolute;top:934px;left:87px;white-space:nowrap" class="ft92">beneath an array of six LEDs delivering 450 nm of light&#160;</p>
<p style="position:absolute;top:952px;left:87px;white-space:nowrap" class="ft92">with an irradiance of 0.5 mw/mm2</p>
<p style="position:absolute;top:964px;left:292px;white-space:nowrap" class="ft97">.</p>
<p style="position:absolute;top:988px;left:87px;white-space:nowrap" class="ft95"><b>V</b></p>
<p style="position:absolute;top:1001px;left:99px;white-space:nowrap" class="ft98"><b>mem&#160;imaging</b></p>
<p style="position:absolute;top:1023px;left:123px;white-space:nowrap" class="ft92">DiBAC</p>
<p style="position:absolute;top:1034px;left:170px;white-space:nowrap" class="ft97">4(3) (bis-(1, 3-dibutylbarbituric acid)&#160;</p>
<p style="position:absolute;top:1041px;left:87px;white-space:nowrap" class="ft92">trimethine&#160;oxonol)&#160;(DiBAC;&#160;Biotium,&#160;Inc,&#160;Hayward,&#160;CA,&#160;</p>
<p style="position:absolute;top:1059px;left:87px;white-space:nowrap" class="ft92">USA)&#160;was&#160;used&#160;to&#160;measure&#160;relative polarization.&#160;Light-</p>
<p style="position:absolute;top:1077px;left:87px;white-space:nowrap" class="ft92">stimulated embryos were transferred into a DiBAC</p>
<p style="position:absolute;top:1088px;left:410px;white-space:nowrap" class="ft97">4(3)&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft92">solution&#160;(1.9&#160;mM&#160;stock&#160;in&#160;DMSO&#160;used&#160;at&#160;1:1000&#160;in&#160;0.1&#160;×&#160;&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft92">MMR), and imaged while&#160;still&#160;in the&#160;DiBAC</p>
<p style="position:absolute;top:100px;left:755px;white-space:nowrap" class="ft97">4(3) solution.&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft92">An Olympus BX-61 equipped with a Hamamatsu ORCA&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft92">AG&#160;CCD camera, controlled by MetaMorph software, was&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft92">used&#160;for&#160;imaging.&#160;DiBAC</p>
<p style="position:absolute;top:154px;left:641px;white-space:nowrap" class="ft97">4(3)&#160;filters&#160;were:&#160;EX&#160;470/20;&#160;BS&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft92">485; EM 517/23 (Chroma filter set 41001).</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft95"><b>RNA&#160;extraction and cDNA&#160;synthesis</b></p>
<p style="position:absolute;top:231px;left:523px;white-space:nowrap" class="ft92">RNA&#160;extraction was achieved using RNeasy Mini&#160;</p>
<p style="position:absolute;top:249px;left:487px;white-space:nowrap" class="ft92">Kit (50) (QIAGEN 74104).&#160;Tadpoles (collected&#160;<i>n =</i>&#160;10 per&#160;</p>
<p style="position:absolute;top:267px;left:487px;white-space:nowrap" class="ft92">Eppendorf&#160;tube,&#160;three&#160;biological&#160;replicates)&#160;were&#160;put&#160;into&#160;</p>
<p style="position:absolute;top:285px;left:487px;white-space:nowrap" class="ft92">10 volumes of RNAlater solution. RNAlater-stabilized&#160;</p>
<p style="position:absolute;top:303px;left:487px;white-space:nowrap" class="ft92">tissues were then removed from the reagent using forceps&#160;</p>
<p style="position:absolute;top:321px;left:487px;white-space:nowrap" class="ft92">and placed into 2 ml Eppendorf tubes with 600 ul of B-ME&#160;</p>
<p style="position:absolute;top:339px;left:487px;white-space:nowrap" class="ft92">containing Buffer RLT&#160;for disruption and homogenization.&#160;</p>
<p style="position:absolute;top:357px;left:487px;white-space:nowrap" class="ft92">Disruption and homogenization of tissue was achieved&#160;</p>
<p style="position:absolute;top:375px;left:487px;white-space:nowrap" class="ft92">using MICROSONTM XL&#160;2000 ULTRASONIC&#160;</p>
<p style="position:absolute;top:393px;left:487px;white-space:nowrap" class="ft92">LIQUID&#160;PROCESSOR.&#160;The&#160;lysate&#160;was&#160;then&#160;centrifuged&#160;</p>
<p style="position:absolute;top:411px;left:487px;white-space:nowrap" class="ft92">for 3 minutes at full speed and the supernatant (lysate)&#160;</p>
<p style="position:absolute;top:429px;left:487px;white-space:nowrap" class="ft92">was put into a new microcentrifuge tube.&#160;After adding&#160;</p>
<p style="position:absolute;top:447px;left:487px;white-space:nowrap" class="ft92">and pipet-mixing 1 volume of 70% Ethanol into the&#160;</p>
<p style="position:absolute;top:465px;left:487px;white-space:nowrap" class="ft92">lysate, 700 ul of the resultant sample was transferred to&#160;</p>
<p style="position:absolute;top:483px;left:487px;white-space:nowrap" class="ft92">RNeasy spin column. Following the steps outlined in the&#160;</p>
<p style="position:absolute;top:501px;left:487px;white-space:nowrap" class="ft92">RNeasy&#160;MiniHandbook&#160;04/2006,&#160;we&#160;completed&#160;series&#160;of&#160;</p>
<p style="position:absolute;top:519px;left:487px;white-space:nowrap" class="ft92">treatments&#160;with&#160;buffer&#160;RW1,&#160;RPE&#160;and&#160;RNase-free&#160;water&#160;</p>
<p style="position:absolute;top:537px;left:487px;white-space:nowrap" class="ft92">to obtain total RNA. RNA&#160;yield and quality were assessed&#160;</p>
<p style="position:absolute;top:555px;left:487px;white-space:nowrap" class="ft92">by spectrophotometry (ND-1000, NanoDrop) and gel&#160;</p>
<p style="position:absolute;top:573px;left:487px;white-space:nowrap" class="ft92">electrophoresis, respectively, to assess integrity of 28S&#160;</p>
<p style="position:absolute;top:591px;left:487px;white-space:nowrap" class="ft92">and 18S RNA.</p>
<p style="position:absolute;top:609px;left:523px;white-space:nowrap" class="ft92">Reverse transcription was performed using&#160;</p>
<p style="position:absolute;top:627px;left:487px;white-space:nowrap" class="ft92">ThermoScript&#160;RT-PCR&#160;System&#160;(Life&#160;Technologies).&#160;Each&#160;</p>
<p style="position:absolute;top:645px;left:487px;white-space:nowrap" class="ft93"><i>in vitro</i>&#160;reverse transcription reaction was performed using&#160;</p>
<p style="position:absolute;top:663px;left:487px;white-space:nowrap" class="ft92">1&#160;μg&#160;of&#160;total&#160;RNA&#160;and&#160;50&#160;μg&#160;of&#160;oligo(dT)20&#160;primers&#160;(Life&#160;</p>
<p style="position:absolute;top:681px;left:487px;white-space:nowrap" class="ft92">Technologies). RNA&#160;and primers were mixed, denatured&#160;</p>
<p style="position:absolute;top:699px;left:487px;white-space:nowrap" class="ft92">for 5 min at 65°C, and placed on ice before adding the&#160;</p>
<p style="position:absolute;top:717px;left:487px;white-space:nowrap" class="ft92">reaction&#160;mix&#160;according&#160;to&#160;the&#160;manufacturer’s&#160;instructions.&#160;</p>
<p style="position:absolute;top:735px;left:487px;white-space:nowrap" class="ft92">Reverse transcription&#160;reaction&#160;was carried&#160;out at 50°C&#160;</p>
<p style="position:absolute;top:753px;left:487px;white-space:nowrap" class="ft92">for 45 min.&#160;The reaction was terminated by incubating&#160;</p>
<p style="position:absolute;top:771px;left:487px;white-space:nowrap" class="ft92">at&#160;85°C&#160;for&#160;5&#160;min,&#160;followed&#160;by RNA&#160;degradation&#160;using&#160;&#160;</p>
<p style="position:absolute;top:789px;left:487px;white-space:nowrap" class="ft92">1&#160;μg&#160;of&#160;RNase&#160;H&#160;for&#160;20&#160;min&#160;at&#160;37°C.&#160;The&#160;complementary&#160;</p>
<p style="position:absolute;top:807px;left:487px;white-space:nowrap" class="ft92">DNA&#160;(cDNA)&#160;was&#160;stored&#160;at&#160;−20°C&#160;until&#160;use.&#160;The&#160;quality&#160;</p>
<p style="position:absolute;top:825px;left:487px;white-space:nowrap" class="ft92">and quantity of cDNA&#160;were validated using&#160;Advantage 2&#160;</p>
<p style="position:absolute;top:843px;left:487px;white-space:nowrap" class="ft92">PCR&#160;kit&#160;(Clontech)&#160;on&#160;cDNA&#160;samples&#160;using&#160;Orinithine&#160;</p>
<p style="position:absolute;top:861px;left:487px;white-space:nowrap" class="ft92">Decarboxylase (ODC) primers.</p>
<p style="position:absolute;top:897px;left:487px;white-space:nowrap" class="ft95"><b>Quantitative real-time PCR</b></p>
<p style="position:absolute;top:932px;left:523px;white-space:nowrap" class="ft92">Primers&#160;were&#160;designed&#160;using&#160;Genius&#160;for&#160;myogenic&#160;</p>
<p style="position:absolute;top:950px;left:487px;white-space:nowrap" class="ft92">differentiation&#160;1&#160;(Myod1)&#160;and&#160;myogenic&#160;differentiation&#160;</p>
<p style="position:absolute;top:968px;left:487px;white-space:nowrap" class="ft92">1&#160;(Cdh15).&#160;ODC,&#160;a&#160;widely&#160;used&#160;endogenous&#160;control&#160;for&#160;</p>
<p style="position:absolute;top:986px;left:487px;white-space:nowrap" class="ft92">Xenopus, was used to normalize target gene expression.&#160;</p>
<p style="position:absolute;top:1004px;left:487px;white-space:nowrap" class="ft92">The&#160;&#160;PCR&#160;&#160;specificity&#160;&#160;was&#160;&#160;verified&#160;&#160;by&#160;&#160;BLAST&#160;&#160;(http://</p>
<p style="position:absolute;top:1022px;left:487px;white-space:nowrap" class="ft92">blast.ncbi.nlm.nih.gov/Blast.cgi)&#160;&#160;using&#160;&#160;the&#160;&#160;National&#160;</p>
<p style="position:absolute;top:1040px;left:487px;white-space:nowrap" class="ft92">Center for Biotechnology Information&#160;X. laevis reference&#160;</p>
<p style="position:absolute;top:1058px;left:487px;white-space:nowrap" class="ft92">sequence. Desalted primers were obtained from Invitrogen&#160;</p>
<p style="position:absolute;top:1076px;left:487px;white-space:nowrap" class="ft92">by Life&#160;Technologies as follows: MyoD1-Forward&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>6fc8d60849732353c701eb07f0250484-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft100{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft101{font-size:11px;font-family:Times;color:#211f21;}
	.ft102{font-size:13px;font-family:Times;color:#211f21;}
	.ft103{font-size:14px;font-family:Times;color:#211f21;}
	.ft104{font-size:6px;font-family:Times;color:#211f21;}
	.ft105{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft106{font-size:13px;font-family:Times;color:#211f21;}
	.ft107{font-size:6px;font-family:Times;color:#211f21;}
	.ft108{font-size:11px;line-height:18px;font-family:Times;color:#211f21;}
	.ft109{font-size:11px;line-height:17px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page10-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft100">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft101">19584</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft100">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft102">CCGAGGGCAGTCCCTGTT;&#160;MydoD1-Reverse&#160;TGGGA&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft102">CAGTTGAGTGCAGG;&#160;&#160;Cdh15-Forward&#160;&#160;ACAATCGT&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft102">CCAGTGTTTGTGC;&#160;&#160;Cdh15-Reverse&#160;&#160;GTTCAGCATT&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft102">GTCTGTCCTTGG.&#160;For&#160;each&#160;primer&#160;pair,&#160;standard&#160;curve&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft102">primer analysis was performed using serial dilutions of&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft102">cDNA&#160;from&#160;control&#160;embryos&#160;[1&#160;(undiluted),&#160;10−1,&#160;10−2,&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft102">10−3].&#160;&#160;Formation&#160;&#160;of&#160;&#160;primer-dimer&#160;&#160;and&#160;&#160;amplification&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft102">specificity&#160;&#160;was&#160;&#160;assessed&#160;&#160;by&#160;&#160;efficiency&#160;&#160;and&#160;&#160;melt&#160;&#160;curve&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft102">analysis.&#160;The cDNA&#160;from validated RNA&#160;was used to&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft102">perform&#160;&#160;RT-qPCR&#160;&#160;assays.&#160;&#160;For&#160;&#160;each&#160;&#160;biological&#160;&#160;sample,&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft102">three&#160;&#160;technical&#160;&#160;replicates&#160;&#160;were&#160;&#160;run&#160;&#160;in&#160;&#160;each&#160;&#160;RT-qPCR&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft102">experiment.&#160;&#160;Each&#160;&#160;treatment&#160;&#160;contained&#160;&#160;five&#160;&#160;biological&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft102">replicates.&#160;Triplicate negative controls lacking template&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft102">were also run for each&#160;cDNA&#160;sample&#160;for&#160;each reaction.&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft102">PCRs&#160;were&#160;assembled&#160;manually.&#160;Samples&#160;were&#160;prepared&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft102">by&#160;adding&#160;1&#160;μl&#160;of&#160;cDNA&#160;(diluted&#160;1:5&#160;in&#160;ddH2O),&#160;10&#160;μl&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft102">of&#160;2&#160;×&#160;Power&#160;SYBR&#160;Green&#160;PCR&#160;Master&#160;Mix&#160;(Applied&#160;</p>
<p style="position:absolute;top:376px;left:87px;white-space:nowrap" class="ft102">Biosystems),&#160;and&#160;0.5&#160;μl&#160;of&#160;each&#160;primer&#160;(diluted&#160;to&#160;10&#160;μM)&#160;</p>
<p style="position:absolute;top:394px;left:87px;white-space:nowrap" class="ft102">in&#160;a&#160;final&#160;volume&#160;of&#160;20&#160;μl.&#160;Reactions&#160;were&#160;incubated&#160;in&#160;</p>
<p style="position:absolute;top:412px;left:87px;white-space:nowrap" class="ft102">96-well MicroAmp Optical Reaction plates at 95°C for 10&#160;</p>
<p style="position:absolute;top:430px;left:87px;white-space:nowrap" class="ft102">min followed by 40 cycles at 95°C for 15 s and at 60°C&#160;</p>
<p style="position:absolute;top:448px;left:87px;white-space:nowrap" class="ft102">for&#160;1&#160;min&#160;in&#160;a&#160;StepOnePlus&#160;qPCR&#160;instrument&#160;(Applied&#160;</p>
<p style="position:absolute;top:466px;left:87px;white-space:nowrap" class="ft102">Biosystems).&#160;The&#160;RT-qPCR&#160;data&#160;were&#160;analyzed&#160;using&#160;the&#160;</p>
<p style="position:absolute;top:484px;left:87px;white-space:nowrap" class="ft102">StepOne&#160;software&#160;v.2.3,&#160;and&#160;ΔΔCT&#160;values&#160;were&#160;calculated&#160;</p>
<p style="position:absolute;top:502px;left:87px;white-space:nowrap" class="ft102">(Applied Biosystems). Fold change of target genes relative&#160;</p>
<p style="position:absolute;top:520px;left:87px;white-space:nowrap" class="ft102">to&#160;the&#160;amount&#160;of&#160;the&#160;control&#160;gene&#160;ODC&#160;was&#160;calculated&#160;as&#160;</p>
<p style="position:absolute;top:538px;left:87px;white-space:nowrap" class="ft102">2^-ΔΔCT.</p>
<p style="position:absolute;top:574px;left:87px;white-space:nowrap" class="ft103"><b>Statistics</b></p>
<p style="position:absolute;top:609px;left:123px;white-space:nowrap" class="ft102">Following the appropriate light regimens, stimulated&#160;</p>
<p style="position:absolute;top:627px;left:87px;white-space:nowrap" class="ft102">construct-expressing&#160;embryos were&#160;compared&#160;–&#160;for&#160;</p>
<p style="position:absolute;top:645px;left:87px;white-space:nowrap" class="ft102">ITLS incidence – to their expressing but un-stimulated&#160;</p>
<p style="position:absolute;top:663px;left:87px;white-space:nowrap" class="ft102">counterparts using a χ2&#160;test (α = 0.01).</p>
<p style="position:absolute;top:699px;left:87px;white-space:nowrap" class="ft103"><b>Pharmacological agents</b></p>
<p style="position:absolute;top:734px;left:123px;white-space:nowrap" class="ft102">The stages selected for the antineoplastic drugs&#160;</p>
<p style="position:absolute;top:752px;left:87px;white-space:nowrap" class="ft102">mirror those of the light treatment. Embryos with ITLS&#160;</p>
<p style="position:absolute;top:770px;left:87px;white-space:nowrap" class="ft102">between St. 28–35 were selected, treated with the drugs,&#160;</p>
<p style="position:absolute;top:788px;left:87px;white-space:nowrap" class="ft102">and scored for ITLS between&#160;St. 45–47. Concentration&#160;of&#160;</p>
<p style="position:absolute;top:806px;left:87px;white-space:nowrap" class="ft102">the&#160;drugs&#160;and&#160;their&#160;effects&#160;on&#160;control&#160;embryos&#160;vs&#160;embryos&#160;</p>
<p style="position:absolute;top:824px;left:87px;white-space:nowrap" class="ft102">with ITLS are given below. Following the manufacture’s&#160;</p>
<p style="position:absolute;top:842px;left:87px;white-space:nowrap" class="ft102">instruction&#160;we prepared&#160;stock&#160;solutions&#160;in&#160;DMSO of&#160;</p>
<p style="position:absolute;top:860px;left:87px;white-space:nowrap" class="ft102">Selumetinib,&#160;Pictilisib,&#160;and&#160;Vemurafenib&#160;in&#160;concentration&#160;</p>
<p style="position:absolute;top:878px;left:87px;white-space:nowrap" class="ft102">of&#160;100&#160;mM,&#160;50&#160;mM,&#160;and&#160;25&#160;mM,&#160;respectively.&#160;Embryos&#160;</p>
<p style="position:absolute;top:896px;left:87px;white-space:nowrap" class="ft102">were&#160;then&#160;exposed&#160;in&#160;0.1&#160;×&#160;MMR&#160;for&#160;the&#160;stages&#160;indicated&#160;</p>
<p style="position:absolute;top:914px;left:87px;white-space:nowrap" class="ft102">to:&#160;&#160;Selumetinib&#160;&#160;–100&#160;&#160;nMm,&#160;&#160;Pictillisib&#160;&#160;–1&#160;&#160;µM,&#160;&#160;and&#160;</p>
<p style="position:absolute;top:932px;left:87px;white-space:nowrap" class="ft102">Vemurafenib –1 µM.&#160;All three compounds were obtained&#160;</p>
<p style="position:absolute;top:950px;left:87px;white-space:nowrap" class="ft102">from Selleckchem.</p>
<p style="position:absolute;top:986px;left:87px;white-space:nowrap" class="ft105"><b>ACKNOWLEDGMENTS AND FUNDING</b></p>
<p style="position:absolute;top:1025px;left:123px;white-space:nowrap" class="ft102">We thank Leonard Zon for the KRAS mutant&#160;</p>
<p style="position:absolute;top:1043px;left:87px;white-space:nowrap" class="ft102">construct, Edward Boyden for&#160;<i>Arch</i>&#160;construct, and&#160;</p>
<p style="position:absolute;top:1061px;left:87px;white-space:nowrap" class="ft102">Christian Bamann for&#160;<i>ChR2D156A</i>&#160;construct.&#160;We thank&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft102">Amber Currier, Erin Switzer, for frog husbandry,&#160;Amanda&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft102">Allen&#160;and&#160;Rakela&#160;Lubonja&#160;for&#160;general&#160;lab&#160;assistance,&#160;and&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft102">Joan&#160;Lemire&#160;and&#160;Jean-Francois&#160;Pare&#160;for&#160;molecular&#160;biology&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft102">assistance.&#160;This work was supported by a grant from&#160;The&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft102">G. Harold and Leila&#160;Y. Mathers Charitable Foundation.</p>
<p style="position:absolute;top:179px;left:487px;white-space:nowrap" class="ft105"><b>CONFLICTS OF&#160;INTEREST</b></p>
<p style="position:absolute;top:215px;left:523px;white-space:nowrap" class="ft102">None.</p>
<p style="position:absolute;top:251px;left:487px;white-space:nowrap" class="ft105"><b>REFERENCES</b></p>
<p style="position:absolute;top:289px;left:487px;white-space:nowrap" class="ft101">&#160;1.&#160;Adams DS, Levin M. Endogenous voltage gradients&#160;</p>
<p style="position:absolute;top:307px;left:514px;white-space:nowrap" class="ft108">as mediators of cell-cell communication: strategies for&#160;<br/>investigating&#160;bioelectrical&#160;signals&#160;during&#160;pattern&#160;formation.&#160;<br/>Cell&#160;Tissue Res. 2013; 352:95–122.</p>
<p style="position:absolute;top:363px;left:487px;white-space:nowrap" class="ft101">&#160;2.&#160;&#160;Adams DS.&#160;A&#160;new tool for tissue engineers: ions as&#160;</p>
<p style="position:absolute;top:381px;left:514px;white-space:nowrap" class="ft108">regulators of morphogenesis during development and&#160;<br/>regeneration.&#160;Tissue engineering. 2008; 14:1461–1468.</p>
<p style="position:absolute;top:420px;left:487px;white-space:nowrap" class="ft101">&#160;&#160;3.&#160;&#160;Chernet BT, Levin M.&#160;Transmembrane&#160;voltage potential&#160;of&#160;</p>
<p style="position:absolute;top:438px;left:514px;white-space:nowrap" class="ft108">somatic&#160;cells controls oncogene-mediated&#160;tumorigenesis&#160;at&#160;<br/>long-range.&#160;Oncotarget.&#160;2014;&#160;5:3287–3306.&#160;doi:&#160;10.18632/<br/>oncotarget.1935.</p>
<p style="position:absolute;top:494px;left:487px;white-space:nowrap" class="ft101">&#160;&#160;4.&#160;&#160;Chernet BT, Levin M.&#160;Transmembrane voltage potential is&#160;</p>
<p style="position:absolute;top:512px;left:514px;white-space:nowrap" class="ft108">an&#160;essential&#160;cellular&#160;parameter&#160;for&#160;the&#160;detection&#160;and&#160;control&#160;<br/>of tumor development in a Xenopus model. Dis Model&#160;<br/>Mech. 2013; 6:595–607.</p>
<p style="position:absolute;top:568px;left:487px;white-space:nowrap" class="ft101">&#160;5.&#160;Tseng&#160;A, Levin M. Cracking the bioelectric code:&#160;</p>
<p style="position:absolute;top:586px;left:514px;white-space:nowrap" class="ft108">Probing&#160;endogenous&#160;ionic&#160;controls&#160;of&#160;pattern&#160;formation.&#160;<br/>Communicative &amp; Integrative Biology. 2013; 6:1–8.</p>
<p style="position:absolute;top:624px;left:487px;white-space:nowrap" class="ft101">&#160;&#160;6.&#160;&#160;Levin M. Bioelectric mechanisms in regeneration: Unique&#160;</p>
<p style="position:absolute;top:642px;left:514px;white-space:nowrap" class="ft108">aspects&#160;and&#160;future&#160;perspectives.&#160;Semin&#160;Cell&#160;Dev&#160;Biol.&#160;2009;&#160;<br/>20:543–556.</p>
<p style="position:absolute;top:681px;left:487px;white-space:nowrap" class="ft101">&#160;&#160;7.&#160;&#160;Levin&#160;&#160;M.&#160;&#160;Large-scale&#160;&#160;biophysics:&#160;&#160;ion&#160;&#160;flows&#160;&#160;and&#160;</p>
<p style="position:absolute;top:699px;left:514px;white-space:nowrap" class="ft101">regeneration.&#160;Trends Cell Biol. 2007; 17:261–270.</p>
<p style="position:absolute;top:719px;left:487px;white-space:nowrap" class="ft101">&#160;8.&#160;&#160;Levin M. Reprogramming cells and tissue patterning&#160;</p>
<p style="position:absolute;top:737px;left:514px;white-space:nowrap" class="ft108">via bioelectrical pathways: molecular mechanisms and&#160;<br/>biomedical opportunities.&#160;Wiley Interdiscip Rev Syst Biol&#160;<br/>Med. 2013.</p>
<p style="position:absolute;top:793px;left:487px;white-space:nowrap" class="ft101">&#160;&#160;9.&#160;&#160;Pullar&#160;&#160;CE.&#160;&#160;(2011).&#160;&#160;The&#160;&#160;physiology&#160;&#160;of&#160;&#160;bioelectricity&#160;&#160;in&#160;</p>
<p style="position:absolute;top:811px;left:514px;white-space:nowrap" class="ft108">development, tissue regeneration, and cancer. Biological&#160;<br/>effects&#160;of&#160;electromagnetics&#160;series.&#160;(Boca&#160;Raton:&#160;CRC&#160;Press).</p>
<p style="position:absolute;top:849px;left:487px;white-space:nowrap" class="ft101">10.&#160;&#160;Chernet&#160;B,&#160;Levin&#160;M.&#160;Endogenous&#160;Voltage&#160;Potentials&#160;and&#160;the&#160;</p>
<p style="position:absolute;top:867px;left:514px;white-space:nowrap" class="ft108">Microenvironment:&#160;Bioelectric&#160;Signals that Reveal, Induce&#160;<br/>and Normalize Cancer. J Clin Exp Oncol. 2013; S1.</p>
<p style="position:absolute;top:906px;left:487px;white-space:nowrap" class="ft101">11.&#160;&#160;Levin M. Endogenous bioelectrical networks store non-</p>
<p style="position:absolute;top:924px;left:514px;white-space:nowrap" class="ft108">genetic patterning information during development and&#160;<br/>regeneration.&#160;&#160;The&#160;&#160;Journal&#160;&#160;of&#160;&#160;physiology.&#160;&#160;2014;&#160;&#160;592:&#160;<br/>2295–2305.</p>
<p style="position:absolute;top:980px;left:487px;white-space:nowrap" class="ft101">12.&#160;&#160;Pai&#160;&#160;VP,&#160;&#160;Martyniuk&#160;&#160;CJ,&#160;&#160;Echeverri,&#160;&#160;K.,&#160;&#160;Sundelacruz,&#160;&#160;S.,&#160;</p>
<p style="position:absolute;top:998px;left:514px;white-space:nowrap" class="ft108">Kaplan, DL, Levin, M. Genome-wide analysis reveals&#160;<br/>conserved transcriptional responses downstream of resting&#160;<br/>potential change in Xenopus embryos, axolotl regeneration,&#160;<br/>and human mesenchymal cell differentiation. Regeneration.&#160;<br/>2015; in minor revision.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>6fc8d60849732353c701eb07f0250484-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft110{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft111{font-size:11px;font-family:Times;color:#211f21;}
	.ft112{font-size:11px;line-height:18px;font-family:Times;color:#211f21;}
	.ft113{font-size:11px;line-height:17px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page11-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft110">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft111">19585</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft110">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:71px;left:87px;white-space:nowrap" class="ft111">13.&#160;&#160;Rao&#160;VR,&#160;Perez-Neut&#160;M,&#160;Kaja&#160;S,&#160;Gentile&#160;S.&#160;Voltage-gated&#160;</p>
<p style="position:absolute;top:89px;left:114px;white-space:nowrap" class="ft112">ion channels&#160;in&#160;cancer cell proliferation.&#160;Cancers (Basel).&#160;<br/>2015; 7:849–875.</p>
<p style="position:absolute;top:128px;left:87px;white-space:nowrap" class="ft111">14.&#160;&#160;Sundelacruz S, Levin M, Kaplan DL. Role of membrane&#160;</p>
<p style="position:absolute;top:146px;left:114px;white-space:nowrap" class="ft112">potential in the regulation of cell proliferation and&#160;<br/>differentiation.&#160;&#160;Stem&#160;&#160;cell&#160;&#160;reviews&#160;&#160;and&#160;&#160;reports.&#160;&#160;2009;&#160;<br/>5:231–246.</p>
<p style="position:absolute;top:203px;left:87px;white-space:nowrap" class="ft111">15.&#160;&#160;Blackiston DJ, McLaughlin KA, Levin M. Bioelectric&#160;</p>
<p style="position:absolute;top:221px;left:114px;white-space:nowrap" class="ft112">controls of cell proliferation: ion channels, membrane&#160;<br/>voltage and the cell cycle. Cell Cycle. 2009; 8:3519–3528.</p>
<p style="position:absolute;top:260px;left:87px;white-space:nowrap" class="ft111">16.&#160;&#160;Urrego&#160;D,&#160;Tomczak&#160;AP,&#160;Zahed&#160;F,&#160;Stuhmer&#160;W,&#160;Pardo&#160;LA.&#160;</p>
<p style="position:absolute;top:278px;left:114px;white-space:nowrap" class="ft112">Potassium&#160;&#160;channels&#160;&#160;in&#160;&#160;cell&#160;&#160;cycle&#160;&#160;and&#160;&#160;cell&#160;&#160;proliferation.&#160;<br/>Philosophical&#160;transactions&#160;of&#160;the&#160;Royal&#160;Society&#160;of&#160;London&#160;<br/>Series B, Biological sciences. 2014; 369:20130094.</p>
<p style="position:absolute;top:335px;left:87px;white-space:nowrap" class="ft111">17.&#160;&#160;Becchetti&#160;A. Ion channels&#160;and transporters in cancer. 1. Ion&#160;</p>
<p style="position:absolute;top:353px;left:114px;white-space:nowrap" class="ft112">channels&#160;and&#160;cell&#160;proliferation&#160;in&#160;cancer.&#160;American&#160;journal&#160;<br/>of physiology Cell physiology. 2011; 301:C255–265.</p>
<p style="position:absolute;top:392px;left:87px;white-space:nowrap" class="ft111">18.&#160;&#160;Kasemeier-Kulesa&#160;JC,&#160;Teddy&#160;JM,&#160;Postovit&#160;LM,&#160;Seftor&#160;EA,&#160;</p>
<p style="position:absolute;top:410px;left:114px;white-space:nowrap" class="ft112">Seftor&#160;&#160;RE,&#160;&#160;Hendrix&#160;&#160;MJ,&#160;&#160;Kulesa&#160;&#160;PM.&#160;&#160;Reprogramming&#160;<br/>multipotent tumor cells with the embryonic neural crest&#160;<br/>microenvironment. Dev Dyn. 2008; 237:2657–2666.</p>
<p style="position:absolute;top:467px;left:87px;white-space:nowrap" class="ft111">19.&#160;Hess&#160;AR, Margaryan NV, Seftor EA, Hendrix&#160;MJ.&#160;</p>
<p style="position:absolute;top:485px;left:114px;white-space:nowrap" class="ft112">Deciphering the signaling events that promote melanoma&#160;<br/>tumor cell vasculogenic mimicry and their link to&#160;<br/>embryonic vasculogenesis: role of the Eph receptors. Dev&#160;<br/>Dyn. 2007; 236:3283–3296.</p>
<p style="position:absolute;top:560px;left:87px;white-space:nowrap" class="ft111">20.&#160;Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-</p>
<p style="position:absolute;top:578px;left:114px;white-space:nowrap" class="ft112">Kulesa&#160;&#160;J,&#160;&#160;Kulesa&#160;&#160;PM,&#160;&#160;Postovit&#160;&#160;LM.&#160;&#160;Reprogramming&#160;<br/>metastatic tumour cells with embryonic microenvironments.&#160;<br/>Nat Rev Cancer. 2007; 7:246–255.</p>
<p style="position:absolute;top:635px;left:87px;white-space:nowrap" class="ft111">21.&#160;&#160;Hendrix MJ, Seftor&#160;EA, Hess&#160;AR, Seftor RE.&#160;Vasculogenic&#160;</p>
<p style="position:absolute;top:653px;left:114px;white-space:nowrap" class="ft112">mimicry and tumour-cell plasticity: lessons from melanoma.&#160;<br/>Nature reviews Cancer. 2003; 3:411–421.</p>
<p style="position:absolute;top:692px;left:87px;white-space:nowrap" class="ft111">22.&#160;&#160;Tarin&#160;D. Clinical&#160;and&#160;Biological&#160;Implications&#160;of the&#160;Tumor&#160;</p>
<p style="position:absolute;top:710px;left:114px;white-space:nowrap" class="ft111">Microenvironment. Cancer Microenviron. 2012.</p>
<p style="position:absolute;top:731px;left:87px;white-space:nowrap" class="ft111">23.&#160;&#160;Maffini&#160;&#160;MV,&#160;&#160;Calabro&#160;&#160;JM,&#160;&#160;Soto&#160;&#160;AM,&#160;&#160;Sonnenschein&#160;&#160;C.&#160;</p>
<p style="position:absolute;top:749px;left:114px;white-space:nowrap" class="ft112">Stromal regulation of neoplastic development: age-<br/>dependent normalization of neoplastic mammary cells by&#160;<br/>mammary&#160;&#160;stroma.&#160;&#160;The&#160;&#160;American&#160;&#160;journal&#160;&#160;of&#160;&#160;pathology.&#160;<br/>2005; 167:1405–1410.</p>
<p style="position:absolute;top:824px;left:87px;white-space:nowrap" class="ft111">24.&#160;&#160;Binggeli&#160;R,&#160;Weinstein&#160;R. Membrane&#160;potentials&#160;and&#160;sodium&#160;</p>
<p style="position:absolute;top:842px;left:114px;white-space:nowrap" class="ft112">channels: hypotheses for growth regulation and cancer&#160;<br/>formation based on changes in sodium channels and gap&#160;<br/>junctions. J&#160;Theor Biol. 1986; 123:377–401.</p>
<p style="position:absolute;top:899px;left:87px;white-space:nowrap" class="ft111">25.&#160;&#160;Burr HS, Strong LC, Smith GM. Bioelectric correlates of&#160;</p>
<p style="position:absolute;top:917px;left:114px;white-space:nowrap" class="ft112">methylcolantherene-induced tumors in mice.&#160;Yale J Biol&#160;<br/>Med. 1938; 10:539–544.</p>
<p style="position:absolute;top:956px;left:87px;white-space:nowrap" class="ft111">26.&#160;&#160;Yang M, Brackenbury&#160;WJ. Membrane potential&#160;and cancer&#160;</p>
<p style="position:absolute;top:974px;left:114px;white-space:nowrap" class="ft111">progression. Front Physiol. 2013; 4:185.</p>
<p style="position:absolute;top:995px;left:87px;white-space:nowrap" class="ft111">27.&#160;&#160;Chen J, Luan&#160;Y,&#160;Yu R, Zhang Z, Zhang J,&#160;Wang&#160;W.&#160;Transient&#160;</p>
<p style="position:absolute;top:1013px;left:114px;white-space:nowrap" class="ft112">receptor&#160;&#160;potential&#160;&#160;(TRP)&#160;&#160;channels,&#160;&#160;promising&#160;&#160;potential&#160;<br/>diagnostic and therapeutic tools for cancer. Biosci&#160;Trends.&#160;<br/>2014; 8:1–10.</p>
<p style="position:absolute;top:71px;left:487px;white-space:nowrap" class="ft111">28.&#160;&#160;Lang F, Stournaras C. Ion channels in cancer: future&#160;</p>
<p style="position:absolute;top:89px;left:514px;white-space:nowrap" class="ft112">perspectives&#160;&#160;and&#160;&#160;clinical&#160;&#160;potential.&#160;&#160;Philosophical&#160;<br/>transactions of the Royal Society of London Series B,&#160;<br/>Biological sciences. 2014; 369:20130108.</p>
<p style="position:absolute;top:148px;left:487px;white-space:nowrap" class="ft111">29.&#160;&#160;Onkal&#160;&#160;R,&#160;&#160;Djamgoz&#160;&#160;MB.&#160;&#160;Molecular&#160;&#160;pharmacology&#160;&#160;of&#160;</p>
<p style="position:absolute;top:166px;left:514px;white-space:nowrap" class="ft112">voltage-gated sodium channel expression in metastatic&#160;<br/>disease: clinical potential of neonatal Nav1.5 in breast&#160;<br/>cancer. Eur J Pharmacol. 2009; 625:206–219.</p>
<p style="position:absolute;top:224px;left:487px;white-space:nowrap" class="ft111">30.&#160;&#160;Fraser&#160;SP,&#160;Pardo&#160;LA.&#160;Ion&#160;channels:&#160;functional&#160;expression&#160;</p>
<p style="position:absolute;top:242px;left:514px;white-space:nowrap" class="ft112">and therapeutic potential in cancer. Colloquium on Ion&#160;<br/>Channels and Cancer. EMBO reports. 2008; 9:512–515.</p>
<p style="position:absolute;top:283px;left:487px;white-space:nowrap" class="ft111">31.&#160;&#160;Brackenbury&#160;WJ, Isom LL.&#160;Voltage-gated Na+ channels:&#160;</p>
<p style="position:absolute;top:301px;left:514px;white-space:nowrap" class="ft112">potential for beta subunits as therapeutic targets. Expert&#160;<br/>opinion on therapeutic targets. 2008; 12:1191–1203.</p>
<p style="position:absolute;top:342px;left:487px;white-space:nowrap" class="ft111">32.&#160;&#160;Huang X, He&#160;Y,&#160;Dubuc&#160;AM,&#160;Hashizume&#160;R,&#160;Zhang&#160;W,&#160;</p>
<p style="position:absolute;top:360px;left:514px;white-space:nowrap" class="ft112">Reimand J,&#160;Yang H,&#160;Wang&#160;TA, Stehbens SJ,&#160;Younger S,&#160;<br/>Barshow S, Zhu S, Cooper MK, et al. EAG2 potassium&#160;<br/>channel with evolutionarily conserved function as a&#160;<br/>brain&#160;&#160;tumor&#160;&#160;target.&#160;&#160;Nat&#160;&#160;Neurosci.&#160;&#160;2015;&#160;&#160;18:1236–46.&#160;&#160;<br/>doi: 10.1038/nn.4088.</p>
<p style="position:absolute;top:455px;left:487px;white-space:nowrap" class="ft111">33.&#160;&#160;Djamgoz&#160;&#160;MB,&#160;&#160;Coombes&#160;&#160;RC,&#160;&#160;Schwab&#160;&#160;A.&#160;&#160;Ion&#160;&#160;transport&#160;</p>
<p style="position:absolute;top:473px;left:514px;white-space:nowrap" class="ft112">and&#160;&#160;cancer:&#160;&#160;from&#160;&#160;initiation&#160;&#160;to&#160;&#160;metastasis.&#160;&#160;Philosophical&#160;<br/>transactions of the Royal Society of London Series B,&#160;<br/>Biological sciences. 2014; 369:20130092.</p>
<p style="position:absolute;top:532px;left:487px;white-space:nowrap" class="ft111">34.&#160;&#160;Arcangeli&#160;A,&#160;Pillozzi&#160;S,&#160;Becchetti&#160;A.&#160;Targeting&#160;ion&#160;channels&#160;</p>
<p style="position:absolute;top:550px;left:514px;white-space:nowrap" class="ft112">in leukemias: a new challenge for treatment. Current&#160;<br/>medicinal chemistry. 2012; 19:683–696.</p>
<p style="position:absolute;top:590px;left:487px;white-space:nowrap" class="ft111">35.&#160;Arcangeli&#160;A, Crociani O, Lastraioli E, Masi&#160;A,&#160;</p>
<p style="position:absolute;top:608px;left:514px;white-space:nowrap" class="ft112">Pillozzi&#160;S,&#160;Becchetti&#160;A.&#160;Targeting&#160;ion&#160;channels&#160;in&#160;cancer:&#160;a&#160;<br/>novel frontier in antineoplastic therapy. Current medicinal&#160;<br/>chemistry. 2009; 16:66–93.</p>
<p style="position:absolute;top:667px;left:487px;white-space:nowrap" class="ft111">36.&#160;&#160;Frede&#160;&#160;J,&#160;&#160;Fraser&#160;&#160;SP,&#160;&#160;Oskay-Ozcelik&#160;&#160;G,&#160;&#160;Hong&#160;&#160;Y,&#160;&#160;Ioana&#160;</p>
<p style="position:absolute;top:685px;left:514px;white-space:nowrap" class="ft112">Braicu&#160;&#160;E,&#160;&#160;Sehouli&#160;&#160;J,&#160;&#160;Gabra&#160;&#160;H,&#160;&#160;Djamgoz&#160;&#160;MB.&#160;&#160;Ovarian&#160;<br/>cancer: Ion channel and aquaporin expression as&#160;<br/>novel&#160;&#160;targets&#160;&#160;of&#160;&#160;clinical&#160;&#160;potential.&#160;&#160;Eur&#160;&#160;J&#160;&#160;Cancer.&#160;&#160;2013;&#160;<br/>49:2331–2344.</p>
<p style="position:absolute;top:762px;left:487px;white-space:nowrap" class="ft111">37.&#160;&#160;Perez-Neut&#160;&#160;M,&#160;&#160;Rao&#160;&#160;VR,&#160;&#160;Gentile&#160;&#160;S.&#160;&#160;hERG1/Kv11.1&#160;</p>
<p style="position:absolute;top:780px;left:514px;white-space:nowrap" class="ft112">activation&#160;stimulates&#160;transcription&#160;of&#160;p21waf/cip&#160;in&#160;breast&#160;<br/>cancer cells via a calcineurin-dependent mechanism.&#160;<br/>Oncotarget. 2015. doi: 10.18632/oncotarget.3797.</p>
<p style="position:absolute;top:839px;left:487px;white-space:nowrap" class="ft111">38.&#160;&#160;Perez-Neut&#160;M,&#160;Shum&#160;A,&#160;Cuevas&#160;BD,&#160;Miller&#160;R,&#160;Gentile&#160;S.&#160;</p>
<p style="position:absolute;top:857px;left:514px;white-space:nowrap" class="ft112">Stimulation of hERG1 channel activity promotes a calcium-<br/>dependent degradation of cyclin E2, but not cyclin E1, in&#160;<br/>breast&#160;cancer&#160;cells.&#160;Oncotarget.&#160;2015;&#160;6:1631–1639.&#160;doi:&#160;<br/>10.18632/oncotarget.2829.</p>
<p style="position:absolute;top:934px;left:487px;white-space:nowrap" class="ft111">39.&#160;&#160;Blackiston D,&#160;Adams DS, Lemire JM, Lobikin M, Levin M.&#160;&#160;</p>
<p style="position:absolute;top:952px;left:514px;white-space:nowrap" class="ft112">Transmembrane potential of GlyCl-expressing instructor&#160;<br/>cells induces a neoplastic-like conversion of melanocytes&#160;<br/>via a serotonergic pathway. Disease models &amp; mechanisms.&#160;<br/>2011; 4:67–85.</p>
<p style="position:absolute;top:1028px;left:487px;white-space:nowrap" class="ft111">40.&#160;&#160;Lobikin M, Chernet B, Lobo D, Levin M. Resting potential,&#160;</p>
<p style="position:absolute;top:1046px;left:514px;white-space:nowrap" class="ft111">oncogene-induced tumorigenesis, and metastasis: the&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>6fc8d60849732353c701eb07f0250484-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft120{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft121{font-size:11px;font-family:Times;color:#211f21;}
	.ft122{font-size:11px;font-family:Times;color:#211f21;}
	.ft123{font-size:11px;line-height:18px;font-family:Times;color:#211f21;}
	.ft124{font-size:11px;line-height:17px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page12-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft120">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft121">19586</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft120">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:71px;left:114px;white-space:nowrap" class="ft123">bioelectric basis of cancer&#160;<i>in vivo</i>.&#160;Physical&#160;biology.&#160;2012;&#160;<br/>9:065002.</p>
<p style="position:absolute;top:112px;left:87px;white-space:nowrap" class="ft121">41.&#160;&#160;Chernet&#160;BT,&#160;Fields&#160;C,&#160;Levin&#160;M.&#160;Long-range&#160;gap&#160;junctional&#160;</p>
<p style="position:absolute;top:130px;left:114px;white-space:nowrap" class="ft123">signaling controls oncogene-mediated&#160;tumorigenesis in&#160;<br/>Xenopus laevis embryos. Front Physiol. 2015; 5:519.</p>
<p style="position:absolute;top:169px;left:87px;white-space:nowrap" class="ft121">42.&#160;&#160;Chernet BT, Levin M.&#160;Transmembrane voltage potential is&#160;</p>
<p style="position:absolute;top:187px;left:114px;white-space:nowrap" class="ft123">an&#160;essential&#160;cellular&#160;parameter&#160;for&#160;the&#160;detection&#160;and&#160;control&#160;<br/>of tumor development in a Xenopus model. Disease models&#160;<br/>&amp; mechanisms. 2013; 6:595–607.</p>
<p style="position:absolute;top:244px;left:87px;white-space:nowrap" class="ft121">43.&#160;&#160;Chernet&#160;B,&#160;Levin&#160;M.&#160;Endogenous&#160;Voltage&#160;Potentials&#160;and&#160;the&#160;</p>
<p style="position:absolute;top:262px;left:114px;white-space:nowrap" class="ft123">Microenvironment:&#160;Bioelectric&#160;Signals that Reveal, Induce&#160;<br/>and Normalize Cancer. J Clin Exp Oncol. 2013; Suppl 1.</p>
<p style="position:absolute;top:301px;left:87px;white-space:nowrap" class="ft121">44.&#160;&#160;Fenno L,&#160;Yizhar O, Deisseroth&#160;K.&#160;The development and&#160;</p>
<p style="position:absolute;top:319px;left:114px;white-space:nowrap" class="ft123">application&#160;&#160;of&#160;&#160;optogenetics.&#160;&#160;Annu&#160;&#160;Rev&#160;&#160;Neurosci.&#160;&#160;2011;&#160;<br/>34:389–412.</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft121">45.&#160;Knopfel&#160;T, Lin MZ, Levskaya&#160;A,&#160;Tian L, Lin JY,&#160;</p>
<p style="position:absolute;top:376px;left:114px;white-space:nowrap" class="ft123">Boyden ES.&#160;Toward the second generation of optogenetic&#160;<br/>tools. J Neurosci. 2010; 30:14998–15004.</p>
<p style="position:absolute;top:415px;left:87px;white-space:nowrap" class="ft121">46.&#160;&#160;Liu&#160;&#160;X,&#160;&#160;Tonegawa&#160;&#160;S.&#160;&#160;Optogenetics&#160;&#160;3.0.&#160;&#160;Cell.&#160;&#160;2010;&#160;</p>
<p style="position:absolute;top:433px;left:114px;white-space:nowrap" class="ft121">141:22–24.</p>
<p style="position:absolute;top:454px;left:87px;white-space:nowrap" class="ft121">47.&#160;Gradinaru&#160;V, Zhang F, Ramakrishnan C, Mattis J,&#160;</p>
<p style="position:absolute;top:472px;left:114px;white-space:nowrap" class="ft123">Prakash&#160;R,&#160;Diester&#160;I,&#160;Goshen&#160;I,&#160;Thompson&#160;KR,&#160;Deisseroth&#160;K.&#160;&#160;<br/>Molecular and cellular approaches for diversifying and&#160;<br/>extending optogenetics. Cell. 2010; 141:154–165.</p>
<p style="position:absolute;top:529px;left:87px;white-space:nowrap" class="ft121">48.&#160;&#160;Adams DS, Lemire JM, Kramer RH, Levin M. Optogenetics&#160;</p>
<p style="position:absolute;top:547px;left:114px;white-space:nowrap" class="ft123">in&#160;Developmental&#160;Biology:&#160;using&#160;light&#160;to&#160;control&#160;ion&#160;flux-<br/>dependent signals in Xenopus embryos.&#160;The International&#160;<br/>journal of developmental biology. 2014; 58:851–861.</p>
<p style="position:absolute;top:604px;left:87px;white-space:nowrap" class="ft121">49.&#160;&#160;Adams DS,&#160;Tseng&#160;AS, Levin M. Light-activation of the&#160;</p>
<p style="position:absolute;top:622px;left:114px;white-space:nowrap" class="ft124">Archaerhodopsin H(+)-pump reverses age-dependent loss&#160;<br/>of vertebrate regeneration: sparking system-level controls&#160;<br/><i>in vivo</i>. Biology open. 2013; 2:306–313.</p>
<p style="position:absolute;top:679px;left:87px;white-space:nowrap" class="ft121">50.&#160;&#160;Lobikin M, Chernet B, Lobo D, Levin M. Resting potential,&#160;</p>
<p style="position:absolute;top:697px;left:114px;white-space:nowrap" class="ft123">oncogene-induced tumorigenesis, and metastasis: the&#160;<br/>bioelectric basis of cancer&#160;<i>in vivo</i>.&#160;Phys&#160;Biol.&#160;2012;&#160;9:065002.</p>
<p style="position:absolute;top:736px;left:87px;white-space:nowrap" class="ft121">51.&#160;&#160;Pai&#160;&#160;VP,&#160;&#160;Aw&#160;&#160;S,&#160;&#160;Shomrat&#160;&#160;T,&#160;&#160;Lemire&#160;&#160;JM,&#160;&#160;Levin&#160;&#160;M.&#160;</p>
<p style="position:absolute;top:754px;left:114px;white-space:nowrap" class="ft123">Transmembrane&#160;voltage&#160;potential&#160;controls&#160;embryonic&#160;<br/>eye&#160;&#160;patterning&#160;&#160;in&#160;&#160;Xenopus&#160;&#160;laevis.&#160;&#160;Development.&#160;&#160;2012;&#160;<br/>139:313–323.</p>
<p style="position:absolute;top:811px;left:87px;white-space:nowrap" class="ft121">52.&#160;&#160;Tseng&#160;AS, Levin M.&#160;Transducing bioelectric signals into&#160;</p>
<p style="position:absolute;top:829px;left:114px;white-space:nowrap" class="ft123">epigenetic pathways during tadpole tail regeneration.&#160;<br/>Anatomical record. 2012; 295:1541–1551.</p>
<p style="position:absolute;top:868px;left:87px;white-space:nowrap" class="ft121">53.&#160;Levin&#160;M.&#160;Molecular&#160;bioelectricity&#160;in&#160;developmental&#160;</p>
<p style="position:absolute;top:886px;left:114px;white-space:nowrap" class="ft123">biology: new tools and recent discoveries: control of cell&#160;<br/>behavior and pattern formation by transmembrane potential&#160;<br/>gradients. Bioessays. 2012; 34:205–217.</p>
<p style="position:absolute;top:943px;left:87px;white-space:nowrap" class="ft121">54.&#160;&#160;Pai&#160;&#160;VP,&#160;&#160;Lemire&#160;&#160;JM,&#160;&#160;Pare&#160;&#160;JF,&#160;&#160;Lin&#160;&#160;G,&#160;&#160;Chen&#160;Y,&#160;&#160;Levin&#160;&#160;M.&#160;</p>
<p style="position:absolute;top:961px;left:114px;white-space:nowrap" class="ft124">Endogenous&#160;Gradients&#160;of&#160;Resting&#160;Potential&#160;Instructively&#160;<br/>Pattern&#160;Embryonic&#160;Neural&#160;Tissue&#160;via&#160;Notch&#160;Signaling&#160;and&#160;<br/>Regulation&#160;of&#160;Proliferation.&#160;The&#160;Journal&#160;of&#160;Neuroscience.&#160;<br/>2015; 35:4366–4385.</p>
<p style="position:absolute;top:1036px;left:87px;white-space:nowrap" class="ft121">55.&#160;&#160;Blackiston DJ,&#160;Anderson GM, Rahman N, Bieck C,&#160;</p>
<p style="position:absolute;top:1054px;left:114px;white-space:nowrap" class="ft123">Levin M.&#160;A&#160;Novel Method for Inducing Nerve Growth&#160;<br/>via&#160;Modulation&#160;of&#160;Host&#160;Resting&#160;Potential:&#160;Gap&#160;Junction-</p>
<p style="position:absolute;top:71px;left:514px;white-space:nowrap" class="ft123">Mediated and Serotonergic Signaling Mechanisms.&#160;<br/>Neurotherapeutics. 2015; 12:170–184.</p>
<p style="position:absolute;top:108px;left:487px;white-space:nowrap" class="ft121">56.&#160;&#160;Nutt LK.&#160;The&#160;Xenopus&#160;oocyte:&#160;a model&#160;for studying&#160;the&#160;</p>
<p style="position:absolute;top:126px;left:514px;white-space:nowrap" class="ft124">metabolic regulation of cancer cell death. Semin Cell Dev&#160;<br/>Biol. 2012; 23:412–418.</p>
<p style="position:absolute;top:164px;left:487px;white-space:nowrap" class="ft121">57.&#160;&#160;Nedelkovska H, Robert J. Hsp72 mediates stronger antigen-</p>
<p style="position:absolute;top:182px;left:514px;white-space:nowrap" class="ft123">dependent non-classical MHC class Ib anti-tumor responses&#160;<br/>than hsc73 in Xenopus laevis. Cancer Immun. 2013; 13:4.</p>
<p style="position:absolute;top:219px;left:487px;white-space:nowrap" class="ft121">58.&#160;&#160;Cross&#160;&#160;MK,&#160;&#160;Powers&#160;&#160;MA.&#160;&#160;Learning&#160;&#160;about&#160;&#160;cancer&#160;&#160;from&#160;</p>
<p style="position:absolute;top:237px;left:514px;white-space:nowrap" class="ft123">frogs: analysis of mitotic&#160;spindles in Xenopus egg extracts.&#160;<br/>Disease models &amp; mechanisms. 2009; 2:541–547.</p>
<p style="position:absolute;top:275px;left:487px;white-space:nowrap" class="ft121">59.&#160;&#160;Goyos&#160;A,&#160;Robert&#160;J.&#160;Tumorigenesis&#160;and&#160;anti-tumor&#160;immune&#160;</p>
<p style="position:absolute;top:293px;left:514px;white-space:nowrap" class="ft123">responses&#160;in&#160;Xenopus.&#160;Front&#160;Biosci&#160;(Landmark&#160;Ed).&#160;2009;&#160;<br/>14:167–176.</p>
<p style="position:absolute;top:330px;left:487px;white-space:nowrap" class="ft121">60.&#160;&#160;Wallingford JB.&#160;Tumors in tadpoles: the Xenopus embryo&#160;</p>
<p style="position:absolute;top:348px;left:514px;white-space:nowrap" class="ft123">as a model system for the study of tumorigenesis.&#160;Trends&#160;<br/>Genet. 1999; 15:385–388.</p>
<p style="position:absolute;top:386px;left:487px;white-space:nowrap" class="ft121">61.&#160;&#160;Kaltenbrun&#160;E,&#160;Tandon&#160;P,&#160;Amin&#160;NM,&#160;Waldron&#160;L,&#160;Showell&#160;C,&#160;</p>
<p style="position:absolute;top:404px;left:514px;white-space:nowrap" class="ft123">Conlon FL. Xenopus:&#160;An emerging model for studying&#160;<br/>congenital&#160;&#160;heart&#160;&#160;disease.&#160;&#160;Birth&#160;&#160;defects&#160;&#160;research&#160;&#160;Part&#160;&#160;A,&#160;<br/>Clinical and molecular teratology. 2011; 91:495–510.</p>
<p style="position:absolute;top:459px;left:487px;white-space:nowrap" class="ft121">62.&#160;&#160;Pratt&#160;&#160;KG,&#160;&#160;Khakhalin&#160;&#160;AS.&#160;&#160;Modeling&#160;&#160;human&#160;</p>
<p style="position:absolute;top:477px;left:514px;white-space:nowrap" class="ft124">neurodevelopmental&#160;disorders&#160;in&#160;the&#160;Xenopus&#160;tadpole:&#160;<br/>from&#160;mechanisms&#160;to&#160;therapeutic&#160;targets.&#160;Disease&#160;models&#160;&amp;&#160;<br/>mechanisms. 2013; 6:1057–1065.</p>
<p style="position:absolute;top:533px;left:487px;white-space:nowrap" class="ft121">63.&#160;&#160;Robert J, Cohen N.&#160;The genus Xenopus as a multispecies&#160;</p>
<p style="position:absolute;top:551px;left:514px;white-space:nowrap" class="ft123">model for evolutionary and comparative immunobiology of&#160;<br/>the 21st century. Dev Comp Immunol. 2011; 35:916–923.</p>
<p style="position:absolute;top:588px;left:487px;white-space:nowrap" class="ft121">64.&#160;&#160;Schmitt SM, Gull M, Brandli&#160;AW. Engineering Xenopus&#160;</p>
<p style="position:absolute;top:606px;left:514px;white-space:nowrap" class="ft123">embryos for&#160;phenotypic&#160;drug&#160;discovery&#160;screening.&#160;<br/>Advanced drug delivery reviews. 2014; 69–70:225–246.</p>
<p style="position:absolute;top:644px;left:487px;white-space:nowrap" class="ft121">65.&#160;Haynes-Gimore N, Banach M, Brown E, Dawes R,&#160;</p>
<p style="position:absolute;top:662px;left:514px;white-space:nowrap" class="ft123">Edholm ES, Kim M, Robert J. Semi-solid tumor model in&#160;<br/>Xenopus&#160;&#160;laevis/gilli&#160;&#160;cloned&#160;&#160;tadpoles&#160;&#160;for&#160;&#160;intravital&#160;&#160;study&#160;<br/>of neovascularization, immune cells and melanophore&#160;<br/>infiltration. Dev Biol. 2015; 408:205–12.</p>
<p style="position:absolute;top:735px;left:487px;white-space:nowrap" class="ft121">66.&#160;&#160;Hardwick&#160;&#160;LJ,&#160;&#160;Philpott&#160;&#160;A.&#160;&#160;An&#160;&#160;oncologists&#160;&#160;friend:&#160;&#160;How&#160;</p>
<p style="position:absolute;top:753px;left:514px;white-space:nowrap" class="ft123">Xenopus&#160;contributes&#160;to&#160;cancer&#160;research.&#160;Dev&#160;Biol.&#160;2015;&#160;<br/>408:180–187.</p>
<p style="position:absolute;top:791px;left:487px;white-space:nowrap" class="ft121">67.&#160;&#160;Yang&#160;&#160;S,&#160;&#160;Lockwood&#160;&#160;A,&#160;&#160;Hollett&#160;&#160;P,&#160;&#160;Ford&#160;&#160;R,&#160;&#160;Kao&#160;&#160;K.&#160;</p>
<p style="position:absolute;top:809px;left:514px;white-space:nowrap" class="ft123">Overexpression of a novel Xenopus rel mRNA&#160;gene&#160;<br/>induces&#160;&#160;tumors&#160;&#160;in&#160;&#160;early&#160;&#160;embryos.&#160;&#160;J&#160;&#160;Biol&#160;&#160;Chem.&#160;&#160;1998;&#160;<br/>273:13746–13752.</p>
<p style="position:absolute;top:864px;left:487px;white-space:nowrap" class="ft121">68.&#160;&#160;Wallingford&#160;&#160;JB,&#160;&#160;Seufert&#160;&#160;DW,&#160;&#160;Virta&#160;&#160;VC,&#160;&#160;Vize&#160;&#160;PD.&#160;&#160;p53&#160;</p>
<p style="position:absolute;top:882px;left:514px;white-space:nowrap" class="ft123">activity&#160;is&#160;essential&#160;for&#160;normal&#160;development&#160;in&#160;Xenopus.&#160;<br/>Curr Biol. 1997; 7:747–757.</p>
<p style="position:absolute;top:920px;left:487px;white-space:nowrap" class="ft121">69.&#160;&#160;Chow BY, Han X, Dobry&#160;AS, Qian X, Chuong&#160;AS,&#160;</p>
<p style="position:absolute;top:938px;left:514px;white-space:nowrap" class="ft123">Li&#160;M,&#160;Henninger&#160;MA,&#160;Belfort&#160;GM,&#160;Lin&#160;Y,&#160;Monahan&#160;PE,&#160;<br/>Boyden ES. High-performance genetically targetable optical&#160;<br/>neural silencing by light-driven proton pumps. Nature.&#160;<br/>2010; 463:98–102.</p>
<p style="position:absolute;top:1011px;left:487px;white-space:nowrap" class="ft121">70.&#160;&#160;Adams DS, Lemire JM, Kramer RH, Levin M. Optogenetics&#160;</p>
<p style="position:absolute;top:1029px;left:514px;white-space:nowrap" class="ft123">in&#160;Developmental&#160;Biology:&#160;using&#160;light&#160;to&#160;control&#160;ion&#160;flux-<br/>dependent signals in Xenopus embryos. Int J Dev Biol.&#160;<br/>2014; 58:851–61.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>6fc8d60849732353c701eb07f0250484-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft130{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft131{font-size:11px;font-family:Times;color:#211f21;}
	.ft132{font-size:11px;line-height:18px;font-family:Times;color:#211f21;}
	.ft133{font-size:11px;line-height:17px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page13-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft130">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft131">19587</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft130">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:71px;left:87px;white-space:nowrap" class="ft131">71.&#160;&#160;Le X, Langenau DM, Keefe MD, Kutok JL, Neuberg DS,&#160;</p>
<p style="position:absolute;top:89px;left:114px;white-space:nowrap" class="ft132">Zon&#160;LI.&#160;Heat&#160;shock-inducible&#160;Cre/Lox&#160;approaches&#160;to&#160;induce&#160;<br/>diverse types of tumors and hyperplasia in transgenic&#160;<br/>zebrafish.&#160;Proc&#160;Natl&#160;Acad&#160;Sci&#160;U&#160;S&#160;A.&#160;2007;&#160;104:9410–9415.</p>
<p style="position:absolute;top:146px;left:87px;white-space:nowrap" class="ft131">72.&#160;&#160;Bamann C, Gueta R, Kleinlogel S, Nagel G, Bamberg E.&#160;</p>
<p style="position:absolute;top:164px;left:114px;white-space:nowrap" class="ft132">Structural&#160;guidance&#160;of&#160;the&#160;photocycle&#160;of&#160;channelrhodopsin-2&#160;<br/>by&#160;&#160;an&#160;&#160;interhelical&#160;&#160;hydrogen&#160;&#160;bond.&#160;&#160;Biochemistry.&#160;&#160;2010;&#160;<br/>49:267–278.</p>
<p style="position:absolute;top:221px;left:87px;white-space:nowrap" class="ft131">73.&#160;Lorenz-Fonfria&#160;VA, Heberle J. Channelrhodopsin&#160;</p>
<p style="position:absolute;top:239px;left:114px;white-space:nowrap" class="ft132">unchained:&#160;structure and mechanism&#160;of a light-gated&#160;cation&#160;<br/>channel. Biochim Biophys&#160;Acta. 2014; 1837:626–642.</p>
<p style="position:absolute;top:278px;left:87px;white-space:nowrap" class="ft131">74.&#160;Adams&#160;DS,&#160;Levin&#160;M.&#160;Measuring&#160;resting&#160;membrane&#160;</p>
<p style="position:absolute;top:296px;left:114px;white-space:nowrap" class="ft132">potential&#160;using&#160;the&#160;fluorescent&#160;voltage&#160;reporters&#160;DiBAC4&#160;<br/>and&#160;&#160;CC2-DMPE.&#160;&#160;Cold&#160;&#160;Spring&#160;&#160;Harbor&#160;&#160;protocols.&#160;&#160;2012;&#160;<br/>2012:459–464.</p>
<p style="position:absolute;top:353px;left:87px;white-space:nowrap" class="ft131">75.&#160;&#160;Adams DS, Levin M. General principles for measuring&#160;</p>
<p style="position:absolute;top:371px;left:114px;white-space:nowrap" class="ft132">resting membrane potential and ion concentration using&#160;<br/>fluorescent&#160;&#160;bioelectricity&#160;&#160;reporters.&#160;&#160;Cold&#160;&#160;Spring&#160;&#160;Harbor&#160;<br/>protocols. 2012; 2012:385–397.</p>
<p style="position:absolute;top:428px;left:87px;white-space:nowrap" class="ft131">76.&#160;&#160;Oviedo NJ, Nicolas CL,&#160;Adams DS, Levin M. Live Imaging&#160;</p>
<p style="position:absolute;top:446px;left:114px;white-space:nowrap" class="ft132">of&#160;&#160;Planarian&#160;&#160;Membrane&#160;&#160;Potential&#160;&#160;Using&#160;&#160;DiBAC4.&#160;&#160;CSH&#160;<br/>Protoc. 2008; 2008:pdb prot5055.</p>
<p style="position:absolute;top:485px;left:87px;white-space:nowrap" class="ft131">77.&#160;&#160;Beane&#160;WS,&#160;Morokuma&#160;J,&#160;Adams&#160;DS,&#160;Levin&#160;M.&#160;A&#160;Chemical&#160;</p>
<p style="position:absolute;top:503px;left:114px;white-space:nowrap" class="ft132">genetics&#160;approach&#160;reveals&#160;H,K-ATPase-mediated&#160;membrane&#160;<br/>voltage&#160;is&#160;required&#160;for planarian&#160;head regeneration.&#160;<br/>Chemistry &amp; Biology. 2011; 18:77–89.</p>
<p style="position:absolute;top:560px;left:87px;white-space:nowrap" class="ft131">78.&#160;&#160;Adams DS, Masi&#160;A, Levin M. H+ pump-dependent changes&#160;</p>
<p style="position:absolute;top:578px;left:114px;white-space:nowrap" class="ft132">in membrane voltage are an early mechanism necessary&#160;<br/>and&#160;&#160;sufficient&#160;&#160;to&#160;&#160;induce&#160;&#160;Xenopus&#160;&#160;tail&#160;&#160;regeneration.&#160;<br/>Development. 2007; 134:1323–1335.</p>
<p style="position:absolute;top:635px;left:87px;white-space:nowrap" class="ft131">79.&#160;&#160;Sebire&#160;NJ,&#160;Malone&#160;M.&#160;Myogenin&#160;and&#160;MyoD1 expression&#160;</p>
<p style="position:absolute;top:653px;left:114px;white-space:nowrap" class="ft132">in&#160;&#160;paediatric&#160;&#160;rhabdomyosarcomas.&#160;&#160;J&#160;&#160;Clin&#160;&#160;Pathol.&#160;&#160;2003;&#160;<br/>56:412–416.</p>
<p style="position:absolute;top:692px;left:87px;white-space:nowrap" class="ft131">80.&#160;&#160;Cessna&#160;MH,&#160;Zhou&#160;H,&#160;Perkins&#160;SL,&#160;Tripp&#160;SR,&#160;Layfield&#160;L,&#160;</p>
<p style="position:absolute;top:710px;left:114px;white-space:nowrap" class="ft132">Daines&#160;C,&#160;Coffin&#160;CM.&#160;Are&#160;myogenin&#160;and&#160;myoD1&#160;expression&#160;<br/>specific&#160;for&#160;rhabdomyosarcoma?&#160;A&#160;study&#160;of&#160;150&#160;cases,&#160;with&#160;<br/>emphasis&#160;on&#160;spindle&#160;cell&#160;mimics.&#160;Am&#160;J&#160;Surg&#160;Pathol.&#160;2001;&#160;<br/>25:1150–1157.</p>
<p style="position:absolute;top:785px;left:87px;white-space:nowrap" class="ft131">81.&#160;Davicioni E,&#160;Anderson MJ, Finckenstein FG,&#160;</p>
<p style="position:absolute;top:803px;left:114px;white-space:nowrap" class="ft132">Lynch&#160;JC,&#160;Qualman&#160;SJ,&#160;Shimada&#160;H,&#160;Schofield&#160;DE,&#160;Buckley&#160;JD,&#160;<br/>Meyer&#160;WH,&#160;Sorensen&#160;PH,&#160;Triche&#160;TJ.&#160;Molecular&#160;classification&#160;<br/>of&#160;rhabdomyosarcoma—genotypic&#160;and&#160;phenotypic&#160;<br/>determinants of diagnosis: a report from the Children’s&#160;<br/>Oncology Group.&#160;Am J Pathol. 2009; 174:550–564.</p>
<p style="position:absolute;top:896px;left:87px;white-space:nowrap" class="ft131">82.&#160;&#160;Lobikin&#160;&#160;M,&#160;&#160;Pare&#160;&#160;JF,&#160;&#160;Kaplan&#160;&#160;DL,&#160;&#160;Levin&#160;&#160;M.&#160;&#160;Selective&#160;</p>
<p style="position:absolute;top:914px;left:114px;white-space:nowrap" class="ft132">depolarization of transmembrane potential alters muscle&#160;<br/>patterning and muscle cell localization in Xenopus laevis&#160;<br/>embryos. Int J Dev Biol. 2015; 59:303–11.</p>
<p style="position:absolute;top:971px;left:87px;white-space:nowrap" class="ft131">83.&#160;&#160;McCaig&#160;CD,&#160;Song&#160;B,&#160;Rajnicek&#160;AM.&#160;Electrical&#160;dimensions&#160;</p>
<p style="position:absolute;top:989px;left:114px;white-space:nowrap" class="ft131">in cell science. J Cell Sci. 2009; 122:4267–4276.</p>
<p style="position:absolute;top:1010px;left:87px;white-space:nowrap" class="ft131">84.&#160;&#160;McCaig&#160;CD,&#160;Rajnicek&#160;AM,&#160;Song&#160;B,&#160;Zhao&#160;M.&#160;Controlling&#160;</p>
<p style="position:absolute;top:1028px;left:114px;white-space:nowrap" class="ft132">cell behavior electrically: current views and future potential.&#160;<br/>Physiol Rev. 2005; 85:943–978.</p>
<p style="position:absolute;top:71px;left:487px;white-space:nowrap" class="ft131">85.&#160;&#160;Levin&#160;&#160;M.&#160;&#160;Morphogenetic&#160;&#160;fields&#160;&#160;in&#160;&#160;embryogenesis,&#160;</p>
<p style="position:absolute;top:89px;left:514px;white-space:nowrap" class="ft132">regeneration, and cancer: non-local control of complex&#160;<br/>patterning. Bio Systems. 2012; 109:243–261.</p>
<p style="position:absolute;top:126px;left:487px;white-space:nowrap" class="ft131">86.&#160;&#160;Arcangeli&#160;A, Carla M, Bene M, Becchetti&#160;A,&#160;Wanke E,&#160;</p>
<p style="position:absolute;top:144px;left:514px;white-space:nowrap" class="ft132">Olivotto&#160;M.&#160;Polar/apolar&#160;compounds&#160;induce&#160;leukemia&#160;cell&#160;<br/>differentiation&#160;by&#160;modulating&#160;cell-surface&#160;potential.&#160;PNAS.&#160;<br/>1993; 90:5858–5862.</p>
<p style="position:absolute;top:200px;left:487px;white-space:nowrap" class="ft131">87.&#160;&#160;Adams DS, Lemire JM, Kramer RH, Levin M. Optogenetics&#160;</p>
<p style="position:absolute;top:218px;left:514px;white-space:nowrap" class="ft132">in&#160;Developmental&#160;Biology:&#160;using&#160;light&#160;to&#160;control&#160;ion&#160;flux-<br/>dependent signals in Xenopus embryos. Int J Dev Biol.&#160;<br/>2014.</p>
<p style="position:absolute;top:273px;left:487px;white-space:nowrap" class="ft131">88.&#160;&#160;Lin&#160;JY,&#160;Lin&#160;MZ,&#160;Steinbach&#160;P,&#160;Tsien&#160;RY.&#160;Characterization&#160;</p>
<p style="position:absolute;top:291px;left:514px;white-space:nowrap" class="ft132">of engineered channelrhodopsin variants with improved&#160;<br/>properties and kinetics. Biophys J. 2009; 96:1803–1814.</p>
<p style="position:absolute;top:329px;left:487px;white-space:nowrap" class="ft131">89.&#160;&#160;Berndt&#160;&#160;A,&#160;&#160;Prigge&#160;&#160;M,&#160;&#160;Gradmann&#160;&#160;D,&#160;&#160;Hegemann&#160;&#160;P.&#160;&#160;Two&#160;</p>
<p style="position:absolute;top:347px;left:514px;white-space:nowrap" class="ft132">open states with progressive proton selectivities in the&#160;<br/>branched&#160;channelrhodopsin-2&#160;photocycle.&#160;Biophys&#160;J.&#160;2010;&#160;<br/>98:753–761.</p>
<p style="position:absolute;top:402px;left:487px;white-space:nowrap" class="ft131">90.&#160;&#160;Fortin DL, Dunn&#160;TW, Kramer RH. Engineering light-</p>
<p style="position:absolute;top:420px;left:514px;white-space:nowrap" class="ft132">regulated&#160;&#160;ion&#160;&#160;channels.&#160;&#160;Cold&#160;&#160;Spring&#160;&#160;Harb&#160;&#160;Protoc.&#160;&#160;2011;&#160;<br/>2011:579–585.</p>
<p style="position:absolute;top:458px;left:487px;white-space:nowrap" class="ft131">91.&#160;&#160;Fortin DL, Dunn&#160;TW, Fedorchak&#160;A,&#160;Allen D, Montpetit R,&#160;&#160;</p>
<p style="position:absolute;top:476px;left:514px;white-space:nowrap" class="ft132">Banghart&#160;&#160;MR,&#160;&#160;Trauner&#160;&#160;D,&#160;&#160;Adelman&#160;&#160;JP,&#160;&#160;Kramer&#160;&#160;RH.&#160;<br/>Optogenetic photochemical control of designer K+ channels&#160;<br/>in&#160;mammalian&#160;neurons.&#160;J&#160;Neurophysiol.&#160;2011;&#160;106:488–496.</p>
<p style="position:absolute;top:531px;left:487px;white-space:nowrap" class="ft131">92.&#160;Caporale&#160;N,&#160;Kolstad&#160;KD,&#160;Lee&#160;T,&#160;Tochitsky&#160;I,&#160;</p>
<p style="position:absolute;top:531px;left:833px;white-space:nowrap" class="ft131">&#160;</p>
<p style="position:absolute;top:549px;left:514px;white-space:nowrap" class="ft132">Dalkara D,&#160;Trauner D, Kramer R, Dan&#160;Y, Isacoff EY,&#160;<br/>Flannery JG. LiGluR restores visual responses in&#160;<br/>rodent&#160;&#160;models&#160;&#160;of&#160;&#160;inherited&#160;&#160;blindness.&#160;&#160;Mol&#160;&#160;Ther.&#160;&#160;2011;&#160;<br/>19:1212–1219.</p>
<p style="position:absolute;top:623px;left:487px;white-space:nowrap" class="ft131">93.&#160;&#160;Bizzarri&#160;M, Cucina&#160;A.&#160;Tumor&#160;and&#160;the&#160;microenvironment:&#160;a&#160;</p>
<p style="position:absolute;top:641px;left:514px;white-space:nowrap" class="ft132">chance&#160;to&#160;reframe&#160;the&#160;paradigm&#160;of&#160;carcinogenesis?&#160;Biomed&#160;<br/>Res Int. 2014; 2014:934038.</p>
<p style="position:absolute;top:678px;left:487px;white-space:nowrap" class="ft131">94.&#160;</p>
<p style="position:absolute;top:678px;left:514px;white-space:nowrap" class="ft132">D’Anselmi F, Masiello MG, Cucina&#160;A,&#160;<br/>Proietti&#160;S,&#160;Dinicola&#160;S,&#160;Pasqualato&#160;A,&#160;Ricci&#160;G,&#160;Dobrowolny&#160;G,&#160;<br/>Catizone&#160;A,&#160;&#160;Palombo&#160;A,&#160;&#160;Bizzarri&#160;&#160;M.&#160;&#160;Microenvironment&#160;<br/>promotes tumor cell reprogramming in human breast cancer&#160;<br/>cell lines. PloS one. 2013; 8:e83770.</p>
<p style="position:absolute;top:770px;left:487px;white-space:nowrap" class="ft131">95.&#160;&#160;Bizzarri&#160;&#160;M,&#160;&#160;Pasqualato&#160;A,&#160;&#160;Cucina&#160;A,&#160;&#160;Pasta&#160;&#160;V.&#160;&#160;Physical&#160;</p>
<p style="position:absolute;top:788px;left:514px;white-space:nowrap" class="ft132">forces and non linear dynamics mould fractal cell shape.&#160;<br/>Quantitative&#160;morphological&#160;parameters&#160;and&#160;cell&#160;phenotype.&#160;<br/>Histol Histopathol. 2013; 28:155–174.</p>
<p style="position:absolute;top:843px;left:487px;white-space:nowrap" class="ft131">96.&#160;Bissell MJ, Labarge MA. Context, tissue plasticity,&#160;</p>
<p style="position:absolute;top:861px;left:514px;white-space:nowrap" class="ft132">and cancer: are tumor stem cells also regulated by the&#160;<br/>microenvironment? Cancer Cell. 2005; 7:17–23.</p>
<p style="position:absolute;top:899px;left:487px;white-space:nowrap" class="ft131">97.&#160;&#160;Kenny&#160;&#160;PA,&#160;&#160;Bissell&#160;&#160;MJ.&#160;&#160;Tumor&#160;&#160;reversion:&#160;&#160;correction&#160;</p>
<p style="position:absolute;top:917px;left:514px;white-space:nowrap" class="ft132">of&#160;malignant&#160;behavior&#160;by&#160;microenvironmental&#160;cues.&#160;<br/>International&#160;&#160;journal&#160;&#160;of&#160;&#160;cancer&#160;&#160;Journal&#160;&#160;international&#160;&#160;du&#160;<br/>cancer. 2003; 107:688–695.</p>
<p style="position:absolute;top:972px;left:487px;white-space:nowrap" class="ft131">98.&#160;Sive HL, Grainger RM, Harland RM. (2000). Early&#160;</p>
<p style="position:absolute;top:990px;left:514px;white-space:nowrap" class="ft132">Development&#160;of&#160;Xenopus Laevis.&#160;(New&#160;York:&#160;Cold&#160;Spring&#160;<br/>Harbor Laboratory Press).</p>
<p style="position:absolute;top:1029px;left:487px;white-space:nowrap" class="ft131">99.&#160;&#160;Nieuwkoop&#160;PD,&#160;Faber&#160;J.&#160;(1967).&#160;Normal&#160;Table&#160;of&#160;Xenopus&#160;</p>
<p style="position:absolute;top:1047px;left:514px;white-space:nowrap" class="ft131">laevis (Daudin). (Amsterdam: North-Holland).</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>6fc8d60849732353c701eb07f0250484-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft140{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft141{font-size:11px;font-family:Times;color:#211f21;}
	.ft142{font-size:11px;line-height:18px;font-family:Times;color:#211f21;}
	.ft143{font-size:11px;line-height:17px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page14-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft140">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft141">19588</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft140">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:71px;left:87px;white-space:nowrap" class="ft141">100.&#160;Zhu F, Skommer J, Huang&#160;Y,&#160;Akagi J,&#160;Adams D, Levin M,&#160;</p>
<p style="position:absolute;top:89px;left:114px;white-space:nowrap" class="ft142">Hall&#160;CJ,&#160;Crosier&#160;PS,&#160;Wlodkowic&#160;D.&#160;Fishing&#160;on&#160;chips:&#160;Up-<br/>and-coming&#160;technological&#160;advances&#160;in&#160;analysis&#160;of&#160;zebrafish&#160;<br/>and Xenopus embryos. Cytometry&#160;A. 2014; 85:921–932.</p>
<p style="position:absolute;top:146px;left:87px;white-space:nowrap" class="ft141">101.&#160;Kawakami K,&#160;Takeda H, Kawakami N, Kobayashi M,&#160;</p>
<p style="position:absolute;top:164px;left:114px;white-space:nowrap" class="ft141">Matsuda N, Mishina M.&#160;A&#160;transposon-mediated gene trap&#160;</p>
<p style="position:absolute;top:71px;left:514px;white-space:nowrap" class="ft142">approach&#160;&#160;identifies&#160;&#160;developmentally&#160;&#160;regulated&#160;&#160;genes&#160;&#160;in&#160;<br/>zebrafish. Dev Cell. 2004; 7:133–144.</p>
<p style="position:absolute;top:110px;left:487px;white-space:nowrap" class="ft141">102.&#160;Gillespie JI.&#160;The distribution of small ions during the&#160;</p>
<p style="position:absolute;top:128px;left:514px;white-space:nowrap" class="ft143">early development of Xenopus laevis and&#160;Ambystoma&#160;<br/>mexicanum embryos. J Physiol. 1983; 344:359–377.</p>
</div>
</body>
</html>
